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Colorectal cancer (CRC) is the third most common cancer in Denmark and with 
almost 5,000 annual cases, the incidence is among the highest in the world. The 
preferred diagnostic procedure for detecting CRC is colonoscopy, either as a test on 
symptomatic patients or as a part of a CRC screening programme. Colonoscopy can 
both diagnose the colorectal cancer and prevent the disease by removal of 
premalignant lesions. Unfortunately, only little research has been devoted to the study 
of colonoscopy quality in Denmark compared with other European countries. 
However, patients undergoing colonoscopy expect that the procedure diagnoses all 
malignant and premalignant lesions, is carried out by highly qualified endoscopists 
and has a very low risk of adverse events. The present thesis addresses several key 
quality indicators related to such expectations. 
In Paper I, post-colonoscopy colorectal cancer (PCCRC) was investigated using 
national registries. The PCCRC rate was significantly higher in Denmark than in 
Sweden and the English National Health Service. The PCCRC rate was falling over 
time, indicating better colonoscopy quality. However, the latest available PCCRC rate 
was still at 7.9% in 2012. Regression analysis found PCCRC to be associated with 
tumours in the right side of the colon, small tumour size, diverticulitis, ulcerative 
colitis, hereditary cancers and a high comorbidity index. 
In Paper II, we attempted to improve colonoscopy quality at Aalborg University 
Hospital measured as the cecum intubation rate (CIR) and polyp detection rate (PDR) 
through training courses. Junior endoscopists were give a module-based 20-day 
supervised training course, while “up-skill”, polypectomy and train the colonoscopy 
trainers courses were held for experienced endoscopists. A continuous colonoscopy 
quality monitoring system was also introduced. Overall, CIR increased significantly 
from 87.1% to 92.1%. Overall PDR increased from 33.6% to 41.7%, but the increase 
was not significant in multivariable regression analysis. 
In Paper III, we investigated adverse events associated with colonoscopy in the North 
Denmark Region. Readmission and death were identified using electronic health 
records and classified, graded and attributed according to the American Society of 
Gastrointestinal Endoscopy lexicon. Overall, the adverse event rate was 9.9‰. The 
majority of complications (5.8‰) were related to non-procedure-related events 
(cardiovascular, pulmonary, thromboembolic, electrolyte imbalance, etc.) rather than 
to procedure-related (bleeding and perforations) events, which accounted for 4.1‰. 
Bleeding and perforation rates were within range of other published studies, albeit in 
the upper interval. Perforation rates were just above or below minimal quality 
assurance standards set in the UK, but far above proposed aspirational targets.  
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In Paper IV, we explored the concept of overall and standardized performance 
indicators (CIR and PDR) through data obtained from the colonoscopy reporting 
system. Guidelines commonly provide specific performance goals related to 
colonoscopy indication and gender as these factors can affect the CIR or PDR. 
However, calculating separate performance goals is tedious, reduces the number of 
procedures available for assessment and prolongs the observation period needed to 
obtain reliable performance estimates. Studies finding overall CIR and overall PDR 
useful have emerged, but validity could be affected by differences in case-mix among 
endoscopists. We calculated standardized performance indicators that adjust for 
differences in endoscopist case-mix (colonoscopy indication, patient age and patient 
gender) and compared them to an overall CIR and overall PDR. Standardization had 
little effect on CIR with a maximum change in CIR of 1.95 percentage points, 
interquartile range [0.27-0.86] percentage points and a more pronounced effect on the 
PDR with a maximum change of 11.21 percentage points, interquartile range [2.05-
6.70] percentage points. Overall CIR seems to be a reasonable performance marker, 
but caution must be taken interpreting performance around minimal acceptable 
standards. Overall PDR could be misleading in endoscopists with an outlier case-mix. 
A free R programme to analyse your own colonoscopy database and explore the 
concept of overall performance markers is available in an open file repository. 
In conclusion, this PhD thesis finds that more CRCs are missed or not prevented by 
colonoscopy in Denmark than in Sweden and in the English National Health Service. 
This finding seems to correlate with scarce colonoscopy quality improvement 
initiatives. Endoscopy training programmes and screening certification have not yet 
been implemented on a national scale. We successfully introduced local training 
programmes and regional quality monitoring which led to an overall improvement in 
CIR. Colonoscopy adverse events remain a problem; and the current standard in the 




Kræft i tyk- og endetarm (CRC) rammer næsten 5.000 danskere årligt og er dermed 
den tredje hyppigste kræftform i Danmark. Incidensen af CRC i Danmark er blandt 
den højeste i verden. Kikkertundersøgelse af tyktarmen (koloskopi) er den fortrukne 
metode til at diagnosticere CRC. Indikationen for koloskopi er enten som diagnostisk 
undersøgelse hos symptomatiske patienter (blod i afføringen eller ændret 
afføringsmønster) eller som led i en screeningsundersøgelse.  Ved koloskopi kan CRC 
diagnosticeres direkte ved at tage biopsier. Det er også muligt at bruge undersøgelsen 
som forebyggelse ved at fjerne polypper, der udgør forstadier til kræft. For at sikre, at 
koloskopi er et trygt redskab til diagnostik og forebyggelse af CRC, kan kvaliteten af 
undersøgelserne måles med forskellige parametre. I Danmark har der desværre ikke 
været stor opmærksomhed på måling af kvaliteten af koloskopi sammenlignet med fx 
England. Fra patientens synspunkt må det dog være en naturlig forventning, at 
undersøgelsen finder alle kræftknuder og forstadier til kræft, at endoskopørerne er 
dygtige, og at der er lille risiko for komplikationer. Det er baggrunden for denne 
afhandling, der består af fire studier: 
I det første studie undersøgte vi CRC, som blev overset eller ikke forebygget ved 
koloskopi, kaldet "post-colonoscopy colorectal cancer" (PCCRC). Til dette formål 
blev der anvendt nationale danske registre. Vi fandt, at PCCRC-raten var signifikant 
højere i Danmark end i Sverige og National Health Service i England. PCCRC-raten 
faldt over tid, hvilket indikerede en bedre koloskopikvalitet sidst i studieperioden, 
men de senest tilgængelige tal fra 2012 viser forsat en PCCRC rate på 7,9%. Vores 
regressionsanalyse fandt, at PCCRC var associeret med tumorer i højre side af colon, 
lille tumorstørrelse, divertikulitis, colitis ulcerosa, arvelig cancer og højt 
komorbiditetsindeks. 
I det andet studie så vi på muligheder for at forbedre kvaliteten af koloskopi på 
Aalborg Universitetshospital gennem træningskurser og målte dette på coecum 
intubationsraten (CIR) og polyp detektionsraten (PDR). Yngre læger 
(introduktionsstilling samt første år af hoveduddannelse) gennemgik et 20-dages 
superviseret træningsprogram, mens en serie af polypektomi- og supervisorkurser 
blev afholdt for mere erfarne koloskopører. Et monitoreringssystem til kontinuerligt 
at vurdere koloskopikvaliteten blev ligeledes indført. CIR steg signifikant fra 87,1% 
til 92,1%. PDR steg fra 33,7% til 41,7%, men stigningen var ikke signifikant i den 
multivariable regressionsanalyse. 
I det tredje studie undersøgte vi risikoen for komplikationer ved koloskopi. Vi 
analyserede koloskopier udført i Region Nordjylland. Genindlæggelse og død blev 
identificeret ud fra patientjournaler og herefter klassificeret, graderet og tilskrevet 
koloskopi i henhold til retningslinjerne fra the American Society of Gastrointestinal 
Endoscopy. Komplikationsraten ved koloskopi var 9,9‰. De fleste komplikationer 
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(5,8‰) skyldtes faktorer, der ikke direkte kunne relateres til proceduren 
(kardiovaskulære, lungemæssige, tromboemboliske, elektrolytubalance, etc.), mens 
procedurerelaterede faktorer (blødning og perforation af tarmen) udgjorde 4,1 ‰. 
Niveauet af blødnings- og perforationskomplikationer var sammenligneligt med andre 
publicerede studier, omend i den øvre del af det forventede niveau. Perforationsraten 
lå tæt på minimumsstandarderne i de engelske retningslinjer, men langt fra den 
ønskede standard. 
I det fjerde studie undersøgte vi muligheden for at anvende universelle og 
standardiserende performanceestimater som markør for koloskopikvaliteten (CIR og 
PDR). Guidelines anvender ofte separate performancemål afhængigt af koloskopi-
indikation og køn, da disse faktorer kan påvirke enten CIR eller PDR. Inddeling i disse  
undergrupper reducerer antallet af procedurer til beregning af de enkelte 
performanceestimater, udvider konfidensintervallerne og forlænger den nødvendige 
observationsperiode for at opnå pålidelige performanceestimater. Enkelte tidligere 
studier har undersøgt universelle performancemarkører og fandt disse anvendelige, 
men validiteten kan påvirkes af forskelle i case-mix blandt endoskopørerne. Vi 
beregnede standardiserede performancemarkører, der justerer for forskelle i 
endoskopørernes case-mix (koloskopiindikation, patientalder og køn) og 
sammenlignede dem med universelle performancemarkører. Standardisering havde 
lille effekt på CIR med en maksimal ændring på 1,95 procent point, interkvartilbredde 
[0,27-0,86] procent point og en større effekt på PDR med en maksimal ændring på 
11,21 procent point, interkvartilbredde [2,05-6,70] procent point. En universel CIR 
kan dermed umiddelbart anvendes som markør for koloskopi-kvaliteten, dog med 
forsigtighed for endoskopører, der performer tæt på minimal acceptabel standard. En 
universel PDR kan være vildledende for endoskopører med et specielt case-mix. Vi 
har udviklet et R program til analyse af koloskopidatabaser, der giver mulighed for at 
undersøge egne universelle performansmarkører, og programmet er frit tilgængeligt. 
Denne afhandling beskriver kvaliteten af koloskopi fra fire vinkler. Vores fund 
indikerer, at flere CRC overses eller ikke bliver forebygget i Danmark sammenlignet 
med Sverige og England. Den mest oplagte forklaring herpå er manglende 
kvalitetsforbedringsinitiativer som fx nationale træningsprogrammer og koloskopør-
akkreditering samt utilstrækkelig kvalitetsmonitorering. I studiet implementerede vi 
lokale træningsprogrammer og løbende koloskopikvalitetsmontorering, hvilket øgede 
andelen af komplette undersøgelser (CIR) signifikant. Komplikationsraten til 
koloskopi er ca. 1%, blødninger og perforationer forekommer på et niveau svarende 
til den minimale acceptable standard efter engelske retningslinjer. Der er således god 
grund til forsat at styrke kvaliteten af koloskopier i Danmark gennem øget uddannelse 
og monitorering. Trods forbedringer er den nuværende monitorering af 
koloskopikvaliteten ikke på niveau med anbefalingerne fra European Society of 
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CHAPTER 1: INTRODUCTION  
1.1. PREFACE 
The idea for this PhD emerged in late 2014 and early 2015 when the world was in a 
different place, at least from a Danish colonoscopy quality viewpoint. The Danish 
colorectal cancer (CRC) screening programme had just been initiated, but results had 
not yet been published. Results were anxiously anticipated as very little was known 
about Danish colonoscopy quality because colonoscopy quality had not been 
measured on a large scale. The lack of quality data was accompanied by a scarcity of 
formal training as a two-day simulator course was the only available training option. 
By tradition, the Danish colonoscopy service is primarily provided by surgeons, 
whereas common practice in most European countries and the United States of 
America (US) is that gastroenterologists perform the majority of procedures. 
The concept of “colonoscopy quality” evolved quickly after the millennium. The US 
multi-society task force on colorectal cancer published their “Quality in the Technical 
Performance of Colonoscopy and the Continuous Quality Improvement Process for 
Colonoscopy” in 2002, setting a list of specific goal and recommendations for 
colonoscopy quality and monitoring.1 The US was not the only country driving 
colonoscopy quality forward. In England, concerns were raised about colonoscopy 
quality, and a nationwide colonoscopy survey was carried out. The study published in 
2004 found appalling results with a very high number of incomplete procedures and 
inadequate training programmes.2 The study led to massive quality improvement 
initiatives with accreditation, individual performance monitoring and training 
programmes. The effect was remarkable. A new nationwide survey published in 2013 
by Gavin et al. found massive improvements.3 The concept of colonoscopy training 
and accreditation did not evolve in Denmark, and the Danish CRC screening 
programme was introduced in 2014 without any formal requirements for screening 
endoscopists. The Danish CRC screening programme tracked performance indicators 
on a hospital level and introduced the concept of performance monitoring to many 
Danish endoscopists. Whether the screening programme or mounting evidence of 
quality improvement outside Danish boundaries was the main driving force is 
unknown, but interest in colonoscopy quality began to rise, also in the North Denmark 
Region.  
Initially, our main focus was to create colonoscopy training courses for junior doctors. 
During the first year of surgical training, a colonoscopy training programme could 
consist of six partly supervised training days scattered over a one-year period. It was 
a nuisance to junior doctors, supervisors and patients alike. It did not take long to 
realize that the need for proper training might extend beyond junior doctors. Some 
“experienced” endoscopists seemed to have a disproportionate amount of incomplete 
procedures. However, separating a bad streak of colonoscopies and consistent inferior 
ASPECTS OF QUALITY IN COLONOSCOPY 
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performance is difficult without an endoscopist monitoring system; the need for such 
a system was apparent.  
An important part of monitoring quality is to monitor complications. Unfortunately, 
we had seen cases of severe adverse events (AEs) related to colonoscopy. Some were 
caused by perforations; others were related to cardiac arrhythmias. Colonoscopy AEs 
had never been examined in a Danish context, and we were keen to investigate the 
full range of potential AEs and to compare Danish rates to rates reported in other 
studies and mentioned in guidelines. 
From a patient perspective, pain, incomplete procedures and AEs sounds bad enough; 
but if at least all possible CRCs are identified or prevented, the procedure might be 
tolerable. Unfortunately, studies on CRC occurring shortly after colonoscopy were 
published, revealing that cancers or precancerous lesions were likely missed.4–8 Using 
the extensive Danish national registries to compare Danish numbers of missed cancers 
with those reported for other countries therefore became a priority. 
Guidelines often recommended different colonoscopy performance targets for 
specific subgroups as several factors can affect the chance of intubating the cecum or 
finding polyps.9–11 However, setting different performance targets for subgroups 
widens confidence limits to a degree where performance monitoring becomes almost 
useless on the individual endoscopist level. We hence decided to calculate 
standardized performance markers and investigate the effect of standardization 
compared to simple, overall performance markers (CIR and PDR). 
This thesis covers four aspects of colonoscopy quality. It offers a national perspective 
on CRC occurring shortly after colonoscopy (Study I), a local perspective to improve 
colonoscopy training, quality monitoring and colonoscopy quality (Study II), a 
regional perspective on colonoscopy AEs (Study III) and a new perspective on 
colonoscopy performance indicators (Study IV). 
Chapter 1 offers a short introduction to many aspects of the subject necessary to 
understand this PhD thesis. For experienced endoscopists, the terminology and 
information in this chapter will be familiar; however, for physicians and non-medical 
personnel unfamiliar with colonoscopy, it provides basic information. Chapters 2 and 
3 specify the precise aims and methodology used in the PhD thesis and related papers. 
Chapter 4 gives a summary of the results of the four studies and relevant results not 
included in the published papers. Chapter 5 covers a general discussion followed by 
conclusion and perspectives in chapter 6 and 7, respectively. Published papers and 
paper drafts are found in the last section of this thesis.
CHAPTER 1: INTRODUCTION 
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1.2. ANATOMY OF THE LARGE INTESTINE 
The gastrointestinal tract (GI tract), strecthing from the oral cavity to the anal verge, 
is generally divided into the upper and lower GI tract. The upper GI tract reaches from 
the oral cavity to the duodenum. Its primay function is transportion of the swallowed 
food bolus and enzymatic digestion. The lower GI tract consists of the small and large 
intestine. The function of the small intestine (jejunum and ileum) is primarily 
absorption of nutrients, while the large intestine (the colon) handles water 
reabsorption and propels the excess waste (feces) for elimination. The colon can be 
divided into several subsegments as seen below:  
Some parts of the colon are relatively fixed, while others remain highly mobile. The  
rectum is bound to the pelvic floor and fixed, while the sigmoid colon has a long 
mesocolon that makes it highly mobile. Ligaments bind the left and right colonic 
flexure to adjacent structures, but the transverse colon connecting the flexures is 
highly mobile with a wide mesocolon. The ascending and descedning colon are 
retroperitoneally located or with a narrow mesocolon, giving them a relatively fixed 
position. The cecum is located intraperitonenally and is usually relativelly mobile. 
The total length of the colon is approx. 1 metre with a wall thickness of 0.2-0.4 cm, 
thickest in the sigmoid colon with gradual thinning towards the cecum.12 The colon 
wall concists of the mucosa (an inner epihetlial layer, the lamina propria and the 
Figure 1 Anatomy of the colon with sub segments 
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muscolaris muscosae), the submucosa, the muscularis layer (with a circular and 
longitudinal muscle layer) and the serosa:  
 
1.3. THE ADENOMA-CARCINOMA SEQUENCE 
The majority of CRCs is believed to originate through the andenoma-carcinona 
sequence first described by Vogelstein et al. in 1988.13,14 Over time, genomic 
alteration in the mucosal epithelial cells occurs, affecting oncogenes and tumour 
suppressor genes. The result is a growth advantage and the formation of an adenoma. 
As mutations increase, so do the growth rate and the amount of dysplasia until a 
malignant polyp and, finally, cancer is the result. A typical CRC has 33-66 gene 
mutations.15 Under normal circumstances, the adenoma-carcinoma sequence is a slow 
process. The timeframe is estimated to be 10.6-25.8 years.16  
 
Figure 3 The adenoma carcinoma sequence 
 
Reprinted (with permission) from:  https://gutscharity.org.uk/advice-and-information/conditions/bowel-cancer/ 
Figure 2 Anatomy of the colonic wall 
Original by Goran tek-en, modified under CC BY-SA 4.0 
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Tumour biology may play an important role in development of CRC; at least three 
predominate pathways are known: the chromosomal instability (CIN) pathway, the 
mismatch repair (MMR) pathway and the serrated pathway.17 The CIN pathway and 
the MMR pathway are generally considered mutually exclusive, while the serrated 
pathway can occur together with the two other pathways.18,19
 THE CIN PATHWAY 
The CIN pathway is the most common pathway, and it is observed in 80% of CRC.20 
It is a result of genetic mutations related to  the adenomatous polyposis coli (APC) 
tumour suppressor gene, the K-ras oncogene and the p53 tumour suppressor gene. 
Germline mutations in the APC gene are responsible for the disease known as familial 
adenomatous polyposis (FAP), where hundreds of polyps develop in the colon, 
inevitably leading to CRC at the age of 35-40 if untreated.21,22 
 THE MMR PATHWAY 
Microsatellites are a sequence of tandem repeats (1-5 base pairs) that are repeated 
many times. They are abundant throughout the human genome and are prone to errors 
during DNA replication. Errors are usually corrected by MMR proteins. However, if 
MMR proteins become incompetent, microsatellite errors accumulate to a state called 
microsatellite instability (MSI).21  The Lynch syndrome is characterized by a germline 
mutation in the MMR proteins that greatly increases the risk of CRC and other 
cancers. Lynch syndrome accounts for approximately 3% of CRC, while MSI is found 
in around 15% of sporadic CRC.23 The duration of the adenoma-carcinoma sequence 
is rapidly increased in patients with Lynch syndrome. The mean time is estimated to 
be three years.24 MSI is associated with an increased risk of post-colonoscopy 
colorectal cancer (PCCRC) among sporadic CRC cases.25–27 
 THE SERRATED PATHWAY 
Sessile serrated adenomas (SSAs) have a flat non-polypoid appearance that is 
distinctive from that of polypoid polyps as seen in Figure 3. SSAs are thought to 
develop from defects in methylation known as CpG island methylator phenotype 
(CIMP), a pathway first described by Toyota et al. in 1999.28 Their macroscopic 
appearance resembles that of benign hyperplastic polyps, and their flat appearance 
makes them more difficult to detect and remove.17 SSAs occur predominantly in the 
right side of the colon. CIMP is associated with PCCRC.18    
1.4. COLORECTAL CANCER EPIDEMIOLOGY  
CRC is the third most common cancer in the world with over 1.8 million new cases 
and 881,000 deaths in 2018.29 The incidence differs much between countries with a 
6-to-8-fold variation. CRC can be considered a marker of socioeconomic 
development.29,30  
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Higher CRC incidence is present among countries with higher Human Development 
Index (HDI) score, a combined score of life expectancy, schooling and income. 
Whenever a country experienced rapid socioeconomic improvements, the CRC 
incidence tended to rise with higher HDI.29 Changes in population demography and 
socioeconomic growth are likely to see an increasing number of CRC cases in the 
future. It is estimated that 2.4 million annual CRC cases will occur world wide by 
2035.31 
Like most other Western countries, Denmark has a high incidence of CRC of around 
80 per 100,000 person years.32 The annual number of cases spiked in 2014 with more 
than 5,000 new cases.32 As seen from Figure 4, the sharp rise in the number of cases 
in 2014 coincides with the introduction of the Danish CRC screening programme.33–
35 Since 2014, the annual number of new Danish CRC cases has declined, most likely 
due to lead time bias. In other high-HDI countries such as the US, the CRC age-
standardized incidence has been declining in individuals > 50 years old for more than 
20 years, but with an increasing incidence among individuals < 50 years old.36 The 
incidence of CRC among young individuals is increasing in Denmark as well.37,38 In 
the US, colonoscopy screening programmes were introduced earlier, but they are 











2010 2011 2012 2013 2014 2015 2016 2017 2018
All CRC
Screening detected CRC
Figure 4 Individuals diagnosed with CRC in Denmark from 2010-2018 
 
Note: Complete numbers of screening-detected CRC from 2018 are unavailable 
due to incomplete data. 
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1.5. CRC DIAGNOSIS, STAGING AND PROGNOSIS 
Colonoscopy remains the gold standard for investigating the colon for pathology such 
as CRC and to perform preoperative histological verification of the disease.40 
Colonoscopy may be performed for various indications but is commonly part of a 
screening programme or diagnostic procedure performed due to lower-GI bleedings, 
anaemia or a change in bowel habits. Modern image modalities such as positron 
emission tomography – computed tomography (PET-CT) or regular computed 
tomography (CT) conducted for other reasons than CRC often give rise to suspicious 
colonic findings warranting a subsequent colonoscopy.  
CRCs in Denmark are classified according to the Tumour, Node, Metastasis (TNM) 
classification system of the Union for International Cancer Control (UICC). The TNM 
classification describes the size and/or extension of the primary tumour (T), the degree 
of spread to regional lymph nodes (N) and presence of distant metastasis (M). The 
anatomical extent of the CRC is grouped in stages according to survival. Stage I has 
a 5-year relative survival comparable to that of the rest of the population, whereas 
only 15-20% of individuals with Stage IV CRC are alive after 5 years in Denmark.41 
The TNM classification is updated regularly; the 8th edition is found in Table 1.42 The 
TNM classification replaced the Dukes classification used in Denmark until 2003.43 
 
Table 1 The TNM classification system and staging (8th edition) with Danish 5-
year relative survival according to UICC stage. 
T: Primary tumour 
Tis Superficial tumour without extension through the muscularis mucosae 
T1 Tumour invades submucosa 
T2 Tumour invades the muscularis layer 
T3 Tumour invades through the muscularis layer into the subserosa 
T4a Tumour growth through the serosa layer but not into nearby tissue/organs  
T4b Tumour growth through the serosa layer and into nearby tissue/organs 
N: Regional lymph nodes 
N0 No spread to regional lymph nodes 
N1a Tumour cells found in 1 regional lymph node 
N1b Tumour cells found in 2 or 3 regional lymph nodes 
N1c Nodules made up of tumour cells found in the structures near 
the colon that do not appear to be lymph nodes 
N2a Tumour cells found in 4 to 6 regional lymph nodes 
N2b Tumour cells found in 7 or more regional lymph nodes 
M: Distant metastases 
M0 No spread to a distant part of the body 
M1a Cancer spreading to 1 other part of the body beyond the colon/rectum 
M1b Cancer spreading to > 1 part of the body other than the colon/rectum 
M1c The cancer has spread to the peritoneal surface. 




 T N M 5-year relative survival 
    Colon (%) Rectum (%) 
Stage 0 Tis N0 M0 - - 
Stage I T1,T2 N0 M0 101 98 
Stage II T3,T4 N0 M0 
89 88 
Stage IIA T3 N0 M0 
Stage IIB T4a N0 M0 
Stage IIC T4b N0 M0 
Stage III Any T N1,N2 M0 
73 80 
Stage IIIA T1,T2 N1 M0 
T1 N2a M0 
Stage IIIB T1,T2 N2b M0 
T2,T3 N2a M0 
T3,T4a N1 M0 
Stage IIIC T3,T4a N2b M0 
T4a N2a M0 
T4b N1,N2 M0 
Stage IV Any T Any N M1 
15 20 
Stage IVA Any T Any N M1a 
Stage IVB Any T Any N M1b 
Stage IVC Any T Any N M1c 
 
1.6. THE ENDOSCOPE: HISTORY, FUNCTIONS AND ADJUNCTS 
Development of the modern endoscope began in the late 1950s and early 1960s with 
the invention of flexible glass fibres. The first snare polypectomy was performed by 
Shinya and Wolff in 1971.44 In the early days, the endoscopist had to look directly 
through a lens into the endoscope. This changed with the introduction of the video 
scope in 1983.45 Since then, flexibility, optic resolution and endoscopic tools have 
vastly improved. A modern endoscope for examining the colon (a colonoscope) 
consists of the flexible tube for insertion into the colon, a scope handle with wheels 
and buttons for tip control, insufflation, suction and washing the lens. A working 
channel is available to insert tools for polyp removal and biopsies. An umbilical cord 
runs from the scope handle to the rack. The rack controls endoscope brightness, 
settings for cutting and haemostasis and outputs for the video monitor. Two additional 
adjuncts are commonly used: narrow-band imaging (NBI) and magnetic endoscope 
imaging (MEI). NBI consists of a series of filters that are applied to the endoscopic 
image to enhance contrast and visibility of the vascular pattern for better adenoma 
diagnosis.46 The MEI provides a real-time presentation of the actual form and 
positioning of the scope through electromagnetic coils embedded within the 
endoscope. Information on scope form and positioning is helpful to achieve higher 
CIR, shorter cecum intubation time and less patient pain.47 Recent advances in 
colonoscopy include artificial intelligence to detect polyps.48  




Figure 5 The colonoscope and endoscopic polyp removal 
1.7. KEY PERFORMANCE INDICATORS 
Key performance indicators reflect a number of performance markers that can be used 
to monitor colonoscopy quality at an individual endoscopist, department or national 
level. A short introduction to performance markers used in this PhD thesis follows 
below: 
Cecum intubation rate (CIR) 
CIR is calculated by the number of procedures where the cecum is reached divided by 
the number of procedures performed. It is a commonly used performance marker 
endorsed by major gastrointestinal societies and guidelines.49–52 The minimum 
acceptable CIR is usually 90-95%. Ambiguity still exists on requirements for 
documentation and potential adjustments. UK guidelines require photographic proof 
that the cecum has been reached, while the Danish CRC screening programme relies 
on a “complete colonoscopy” at the endoscopist’s discretion.34,50 In studies related to 
this thesis, cecum intubation was based on the endoscopist’s documentation of 
intubation of the small intestine or ileocolic anastomosis or visualization of the 
ileocecal valve, triradiate fold or the appendix orificium. The requirements are 
identical to those in the UK national quality audit from 2012.3 Adjustments of CIR 
Top left: The colonoscope tip, controls and working channel. Bottom left: Initiation 
of a colonoscopy in the left side position. Top right: A 15 mm flat polyp. Bottom 
right: Polyp site after hot snare polypectomy. 
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are sometimes performed to exclude certain cases (for instance cases with bad bowel 
preparation). In this thesis, CIR was calculated according to the European guidelines 
where only malignant stenosis is excluded.49 
Polyp detection rate (PDR) 
The PDR is defined by the percentage of colonoscopies where at least one polyp is 
found. The definition of a polyp is at the endoscopist’s discretion. The PDR is believed 
to be a good marker of the adenoma detection rate (ADR).53–55 The PDR has also been 
directly linked to the PCCRC rate.56 
Polypectomy rate  
The polypectomy rate is similar, though not identical, to the PDR. A polyp is usually 
removed upon detection; however, anticoagulant treatment or complex polypectomies 
might postpone removal for a later procedure. Polypectomy is usually coded as a 
procedure code or a billing code allowing for retrospective data analysis. The 
polypectomy rate has been inversely linked to the risk of PCCRC.57,58 
 
Adenoma detection rate (ADR) 
The ADR is defined by the percentage of colonoscopies where at least one adenoma 
is found. The ADR is different from the PDR as only histologically verified adenomas 
are included. A high ADR has been linked to a lower risk of PCCRC.59,60 
Mean polyp/adenoma per positive procedure (mPPP/mAPP) 
Mean polyp per positive procedure (mPPP) refers to the number of polyps found per 
procedure if at least one polyp is found. mAPP is similar to mPPP but only counts 
verified adenomas. 
 
Withdrawal time (WT) 
Refers to the time spent withdrawing the scope from the cecum to the anal verge. WTs 
of more than 6-10 minutes are associated with higher PDR/ADR and PCCRC.61,62 
Only procedures without endoscopic interventions are counted when measuring WT. 
When measuring WT in this PhD, colonoscopies with polypectomies or biopsies due 
to suspected inflammatory bowel disease (IBD) or CRC are excluded. 
 
Polyp retrieval rate (PRR) 
PRR refers to the percentage of removed polyps that are retrieved and sent for 
pathological examination. UK guidelines set a PRR target of > 90%.50 
 
Post-colonoscopy colorectal cancer rate (PCCRC rate) 
PCCRC refers to CRC that occurs shortly after a negative colonoscopy (a colonoscopy 
without a malignant finding). The term interval CRC is sometimes used 
interchangeably but refers to a scheduled follow-up, which might not always be the 
case. The timeframe for investigating PCCRC when calculating rates is usually 3 
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years and referred to as the PCCRC-3yr rate. The PCCRC-3yr rate is usually 
calculated by: 




where PCCRC is the number colonoscopies with a CRC occurring 6-36 months after 
colonoscopy and DC (diagnosed cancers) is the number of colonoscopies with a CRC 
from 0-6 months after colonoscopy.63,64 
Number of colonoscopies 
A high procedure volume per endoscopist does not necessarily reflect competence; 
however, a number of initial procedures are needed to learn the procedure and a 
certain number of annual procedures is necessary to stay familiar with the procedure. 
Studies suggest that it takes 175-500 procedures to become competent in 
colonoscopy.65–68 Guidelines recommended a minimum of 100-300 procedures per 
year for each endoscopist.49,50 Studies have found associations between endoscopist 
volume and the PCCRC rate.58,69  
 
Nurse-reported comfort level (NRCL) 
NRCL also known as the Gloucester Comfort Score measures the patient’s discomfort 
on a level from one to five.3,70 The attending nurse judges the patient’s experience by 
the severity and frequency of pain. A score of three or less is generally considered 
acceptable. A description of the NRCL is found in Table 2. It has been speculated that 
isolated focus on performance indicators such as CIR could cause some endoscopists 
to exert additional force (and discomfort) to reach the cecum. Evidence so far does 
not support this thesis as higher CIR and higher PDR rates are associated with lower 
NRCL scores.70       
 
Table 2 Nurse-reported comfort levels of 1-5 with definitions 
1. Comfortable: Talking/comfortable throughout 
2. Minimal: One or two episodes of mild discomfort without distress 
3. Mild: More than two episodes of mild discomfort without distress 
4. Moderate: Significant discomfort experienced several times with some distress 
5. Severe: Frequent discomfort with significant distress 
 
Adverse event rate 
Colonoscopy is not a risk-free procedure as it carries risks for morbidity and mortality. 
AEs can by procedure related (perforation and bleedings) or non-procedure related 
(cardiovascular, dehydration, electrolyte disturbance, etc.). Timeframes and methods 
for investigating AEs are variable, making them difficult to compare.49,71,72 
Continuous tracking of AEs is recommended by major guidelines and societies.9,49,73 
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1.8. COLONOSCOPY IN DENMARK 
The annual number of colonoscopies in Denmark has increased from around 20,000 
procedures in the year of 2000 to almost 120,000 procedures in 2018. The vast 
majority of procedures including screening are performed in surgical 
gastroenterology units. By 2018, 86% of procedures were performed in surgical 





The situation is different from that of other European countries and the US where 
the proportion of colonoscopies performed by gastroenterologists is higher than in 
Denmark.3,74,75 At present, there are no national Danish colonoscopy accreditation, 
certification or training programmes beyond 1-2-day courses for physicians, but 
surgical gastroenterology trainees are required to do 200 colonoscopies during their 
5-year training programme. As demand for colonoscopies increased, a national 
(colonoscopy) training programme for nurses was established in 2011. This 
programme certifies nurses to perform colonoscopies with polypectomies up to 10 
mm. The programme has a theoretical and practical part with 150 supervised 
colonoscopies to be completed within one year.76 Certified colonoscopy nurses are 
required to do 100 colonoscopies / year to remain active. Currently, > 50 certified 
colonoscopy nurses are active in Denmark.  
Individual endoscopist performance monitoring has not been implemented at a 
national level in Denmark. There is no national database such as the UK National 











































1Other: All other fields of specialty and not specified. Source: DNPR (section 1.9 
and section 3.1). 
 
Figure 6 Number of annual colonoscopies performed in Denmark from 2000-
2018 according to specialty.  
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Gastronet.77,78 Regional activities to measure individual endoscopist performance 
indicators have been initiated in the Central Denmark Region.79  
 THE DANISH CRC SCREENING PROGRAMME  
The Danish CRC screening programme was introduced in March 2014.34 The 
programme covers all Danish citizens who are 50-74 years old. Screening of the 
primary cohort was completed in 2017. Since then, all citizens in the cohort are offered 
screening every two years. Individuals are invited by mail with an invitation letter, an 
information leaflet and the faecal immunochemical test (FIT). Returned FITs are 
analysed using the OC Sensor (Eiken Chemical Company, Tokyo) with a cut-off of 
100 µg haemoglobin/L corresponding to 20 µg haemoglobin/g faeces.80 Positive FITs 
are referred for colonoscopy. If the colonoscopy is performed, there are five possible 
outcomes: CRC, high-risk adenoma, middle-risk adenoma, low-risk adenoma or clean 
colon.34,80 Risk assessment is seen in Table 3. In case of a clean colon, the citizen will 
be invited for FIT again after 8 years. 
Table 3 Risk assessment according to colonoscopy findings in the Danish CRC 
screening program 
Low risk Medium risk High risk 
< 3 adenomas 




3 or 4 adenomas 




≥ 5 adenomas 
Adenoma size ≥ 20 mm 
 Follow-up Follow-up Follow-up 
Biennial FIT screening Colonoscopy in 3 years Colonoscopy in 1 year 
 
Participation in the Danish CRC programme has been good with 61% returning the 
FIT test in 2017.34 This is above the 45% minimum standard set by European 
guidelines, but below the desired goal of 65%.81 The FIT was positive in 6.9% of 
individuals and a subsequent colonoscopy was performed in 90% of FIT-positive 
individuals. A CRC was detected in 5.9% of colonoscopies. Annually detected CRC 
in the Danish screening programme can be seen in Figure 4. 
Overall, CIR in the Danish CRC screening programme was low in 2017 (84%), but 
this is mainly due to registrations issues related to the introduction of a new electronic 
health record (EHR) system in the capital region. The range in CIR among hospitals 
outside the capital region was 83-95%. ADR varied from 27-67% among hospitals.34 
Currently, the Danish screening programme measures performance indicators at a 
hospital level, not at an individual endoscopist level.  
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1.9. DENMARK: HEALTH CARE, REGISTRIES AND THE NORTH 
DENMARK REGION 
The Danish healthcare system builds on a universal, free-for-all, public healthcare 
system with very little room for private practice. Combined with a long-lasting 
tradition for national registries, this provides ample opportunities for complete and 
extensive registry studies. The Danish Cancer Registry (DCR) dates back to 1942 with 
mandatory reporting since 1987. It covers all cancer diagnosis based on the 
International Classification of Diseases, 10th Edition (ICD-10) diagnosis, date of 
diagnosis, disease stage and pathology.43 The Danish National Patient Registry 
(DNPR) was established in 1977 and covers admissions to Danish hospitals and 
outpatient units related to diagnoses, treatments and examinations.82 The Danish 
National Prescription Registry (DNPreR) dates back to 1994 and covers all filed 
prescriptions with dates, product name, World Health Organization Anatomical 
Therapeutic Chemical Code (WHO ATC code) and packet size.83  
Another Danish feature is the unique personal identification number (CPR number) 
assigned to each Danish individual upon birth or immigration. The CPR number is 
non-replaceable and follows you for life. Every registration in national registries is 
based upon the CPR number and allows for linkage between multiple registries. 
 THE NORTH DENMARK REGION  
Danish health service is divided into five administrative regions: The North, Central, 
Southern, Zealand and Capital Region. The North Denmark Region is the smallest of 
the five regions with 589,000 inhabitants. Colonoscopies are performed at five 








Figure 7 Endoscopy units in the North Denmark Region 
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Aalborg University hospital covers the main hospital in Aalborg and a satellite unit in 
Hobro. Thisted became a part of Aalborg University hospital in mid 2018; however, 
for consistency Thisted is not included when referring to Aalborg University hospital 
in this PhD. The North Denmark Regional hospital covers the main hospital in 
Hjørring and a satellite unit at Frederikshavn. Endoscopy units in Frederikshavn, 
Hobro and Thisted are outpatient endoscopy units, while Aalborg and Hjørring have 
both surgical and gastroenterology departments.  
1.10. SUMMARY AND RESEARCH GAP 
Demand for colonoscopies has increased in Denmark during the past 20 years with 
surgeons performing the majority of procedures. Little attention has been paid to 
quality monitoring and endoscopist training, which might affect the quality of 
colonoscopy. This PhD thesis investigated colonoscopy quality from four different 
perspectives: A national perspective on PCCRC, CRC occurring shortly after 
colonoscopy (Study I); a local perspective to improve colonoscopy training, quality 
monitoring and colonoscopy quality (Study II); a regional perspective on colonoscopy 
AEs (Study III); and a new perspective on colonoscopy performance indicators (Study 
IV). 
The national perspective focused on CRC occurring shortly after colonoscopy, 
measured by PCCRC rates. PCCRC rates have been investigated in previous studies. 
Unfortunately, previous publications relied on their own unique methods that were 
difficult to compare due to differences in patients’ populations, timeframes, exclusion 
criteria and the calculation of the rate itself. Without a comparable method, it is 
difficult to compare the effect of nationwide colonoscopy quality improvements 
programmes and to compare rates between different countries and jurisdictions. 
Danish registries provide a unique opportunity to calculate rates using multiple 
methods for direct comparison. The World Endoscopy Organization (WEO) 
published their consensus statement for PCCRC in 2019 while we were preparing our 
paper for publication.64 Hopefully, the WEO consensus statement will serve as the 
future reference for calculating PCCRC-3yr rates. We were quick to adopt the 
methodology in our paper. Studies related to associations with PCCRC have been 
examined previously, but not using the vast variables made possible with Danish 
national registries.58,63,84–86 
The local perspective focused on colonoscopy training and quality monitoring in an 
attempt to improve colonoscopy quality. One of the first guidelines recommending 
individual endoscopist performance tracking was issued by Rex et al. in 2002.1 Since 
then, multiple guidelines related to colonoscopy quality assurance and performance 
monitoring have been published by the European Union, the UK, the US and the 
European Society of Gastrointestinal Endoscopy (ESGE).49–52 However, when this 
PhD thesis was initiated, the colonoscopy quality in the North Denmark Region was 
largely unknown and endoscopists were unfamiliar with the concept of individual 
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performance monitoring. Similarly, colonoscopy training programmes were restricted 
to a 2-day simulator course for junior doctors. There was therefore an urgent need for 
training programmes for both junior and experienced endoscopists and for a 
colonoscopy quality monitoring system. 
The regional perspective focus on complications related to colonoscopy occurring 
within the North Denmark Region. Colonoscopy complications have been 
investigated previously in several studies, but ambiguity exists on how to identify 
AEs; other ambiguities are due to variation in follow-up time (3-30 days).49,50,72,87 As 
training and attention to colonoscopy quality have been low in Denmark, we feared 
that complications might be above the proposed thresholds.50 In 2017, colonoscopy 
AEs were validated in the Danish screening programme.88 The screening programme 
relies on positive reporting of complication codes; however, when investigating 
EHRs, a review reported AE rates rising from 0.23% to 0.71%. The review included 
medical complications. However, according to the validation study, only 3 in 14,671 
colonoscopies suffered a medical complication. It seemed like a low number since we 
had observed both cardiac arrest and hypovolemia related to colonoscopy at Aalborg 
University Hospital. The need to investigate colonoscopies outside the screening 
programme and for a wider approach to capture additional complications was 
apparent. The American Society for Gastrointestinal Endoscopy (ASGE) has 
published their lexicon on colonoscopy AEs, which could be an effective tool to 
investigate the full range of AEs.72  
The new perspective on performance indicators relate to the use of overall 
performance markers and standardized performance markers. CIR and PDR/ADR are 
affected by multiple factors such as patient age, patient sex and colonoscopy 
indication; thus, separate performance goals for subgroups are commonly 
provided.10,11,89 Calculating performance goals for subgroups reduces the number of 
procedures available for assessment, thus widening confidence limits and prolonging 
the observation period to obtain reliable results. An alternative approach of applying 
overall CIR and overall PDR comes with a risk as some endoscopists might be unfairly 
suspected of inferior performance due to a difficult case-mix. The concept has been 
explored in few previous studies. Rex et al. studied the use of overall ADR and the 
effect on changes in relation to the minimum acceptable threshold, while Hoff et al. 
studied CIR in clinical vs screening colonoscopies.90,91 Both studies found that overall 
CIR and overall ADR were useful, but generalizability is difficult to evaluate as the 
setup in relation to endoscopy units, patient population and definition of screening 
procedures varies between countries and jurisdictions. Standardized performance 
markers that adjust for differences in case-mix might be an alternative, both as a 
standalone marker and as a tool to investigate the effect of differences in case-mix. 
Additional studies are needed to clarify the reliability of overall performance markers 
and a universal method to investigate the effect of differences in case-mix is 
warranted.  
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CHAPTER 2: AIMS 
The exact aims of each study related to the four aspects of colonoscopy quality are 
found below: 
Study I: Danish PCCRC-3yr rates and factors associated with PCCRC  
• Calculate Danish PCCRC-3yr using identical methods previously published 
from Sweden and the English NHS to allow direct comparison 
• Calculate Danish PCCRC-3yr using the WEO consensus method 
• Identify factors associated with PCCRC in a Danish setting. 
Study II: Improving colonoscopy quality through individualized training programmes  
• Establish local baseline colonoscopy performance (based on CIR and PDR) 
before initiating quality improvement initiatives (2015) 
• Introduce colonoscopy training programmes for junior and experienced 
endoscopists 
• Implement individual colonoscopy performance monitoring in the North 
Denmark Region 
• Measure the overall effect of training programmes using the performance 
monitoring system (based on CIR and PDR) in 2019 
• Compare performance indicators in the North Denmark Region to UK 
quality assurance standards. 
Study III: Colonoscopy AEs in the North Denmark region. 
• Investigate the full range of potential colonoscopy AEs using a standardized 
reporting system 
• Compare AE rates with previously published studies and UK quality 
assurance standards 
• Identify factors that could help reduce future colonoscopy AEs. 
Study IV: Overall and standardized performance indicators 
• To calculate standardized performance markers based on CIR and PDR that 
adjust for colonoscopy indication and patient demographics.  
• To assess individual endoscopist performance using overall performance 
markers vs standardized performance markers.  
• To develop a generic R programme that can be used to generate performance 
benchmarks and test the validity of overall performance markers on any 
colonoscopy database.92






CHAPTER 3: METODS 
35 
 
CHAPTER 3: METHODS 
This section describes the methods used in this PhD in a broader perspective related 
to national registries, the quality monitoring system, colonoscopy training 
programmes, data sources, statistics and ethical considerations. A paper has either 
been published (study I, study II and study III) or drafted (study IV) in relation to each 
study.74,93,94 Further details are available within each paper. 
3.1. STUDY I: DANISH PCCRC-3YR RATES AND FACTORS 
ASSOCIATED WITH PCCRC  
Study I is based on three Danish national registries: The DCR, DNPR and DNPreR 
(section 1.9).43,82,83 A master dataset covering all CRC and colonoscopies from 1 
January 1998 to 31 December 2015 was created by searching the DCR and DNPR. 
CRC was identified using Danish ICD-10 (DC18-DC20) codes, while colonoscopies 
were identified using the Nordic Medico-Statistical Committee (NOMESCO) 
Classification of Surgical Procedure codes: KUJF32 and KUJF35.95 A comorbidity 
database was constructed from the DNPR with comorbidities diagnosed until 31 
December 2015. Crohn’s disease, ulcerative colitis and diverticulitis were defined as 
in the Danish version of the ICD-10: DK50, DK51 and DK57, respectively. 
Hereditary CRC was defined as one of the following Danish ICD-10  codes: DZ848A1 
– familial history of hereditary nonpolyposis CRC, DZ800 – familial history with 
cancer in the GI tract, DD126B – hereditary polyposis coli or DD126F - familial 
adenomatous polyposis. Only comorbidities diagnosed at the time of colonoscopy 
were used for further analysis. The Charlson Co-morbidity Index was calculated based 
on ICD-10 codes as defined by Quan et al. one year prior to date of colonoscopy.96,97 
Uncomplicated diabetes (a part of the Charlson Co-morbidity Index) is usually treated 
by general practitioners. Data from general practitioners are not reported to the DNPR. 
The DNPreR was searched for ATC code: A10 - drugs to treat diabetes. If a 
prescription was identified within one year prior to colonoscopy, a positive diabetes 
diagnosis was assigned. 
3.2. STUDY II: IMPROVING COLONOSCOPY QUALITY THROUGH 
INDIVIDUALIZED TRAINING PROGRAMMES 
The Aalborg University colonoscopy quality baseline was established in 2015 by a 
paper-based survey. Training programmes for experienced and junior endoscopists 
were subsequently developed. The new 2019 performance baseline was established 
by the newly developed quality monitoring system. Figure 8 found below provides an 
overview of the process: 
 





Figure 8 Timing of quality improvement initiatives 
 
 
 2015: BASELINE PERFORMANCE (PAPER-BASED SURVEY) 
The 2015 performance baseline at Aalborg University hospital was established using 
a single page paper-based survey. The survey included the endoscopist’s identification 
number and educational background, indication for colonoscopy, information about 
cecum intubation (or reason for lack of intubation), medicine use, NRCL and number 
of found polyps. Initial information sessions at both Hobro and Aalborg Hospital were 
held to inform endoscopists and assistant nurses about the upcoming survey. The 
survey was distributed with assistance from the medical secretaries. Each survey was 
labelled with the patient CPR number and distributed together with the paper-based 
health records every morning to endoscopists (common procedure in 2015) for a 14-
week period. Unreturned questionnaires were identified from booking records and 
completed using the EHR. A total of 894 surveys were distributed with 838 surveys 
(93.7%) returned by endoscopists. Returned surveys were digitized using EpiData 
Manager and EntryClient (Epidata association – comprehensive data management and 
basic statistical analysis system v4.6.0.2, Odense, Denmark) and subsequently 
exported for statistical analysis in Stata MP 15.1 (StataCorp 2017, College Station, 
TX, US).98–100 
 TRAINING PROGRAMMES FOR EXPERIENCED ENDOSCOPISTS 
The colonoscopy quality improvements were based on a series of courses held by a 
group of English endoscopists considered leading experts in teaching 
colonoscopy.101,102 A total of two skills upgrading, two polypectomy and one train-
the-trainer courses were held from the autumn of 2015 to the spring of 2018. The 
1Individual endoscopist performance monitoring. 2Baseline department performance based on 
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timeline of courses is seen in Figure 8. Each course lasted two days and had six 
participating delegates. Colonoscopies were live-streamed by two cameras covering 
the endoscopy room and the colonoscope video feed with both videos displayed in the 
adjoining room. The delegate performing the procedure and the expert in the 
endoscopy room were both issued with wireless microphones. The remaining 
delegates then watched and discussed the case in the adjoining room. The skills 
upgrading course covered areas such as scope handling, patient positioning and 
techniques to improve visualization and a common colonoscopy teaching language. 
The polypectomy course covered expert advice to improve PDR/ADR, polyp 
classification and polyp removal. The train-the-trainers courses were offered to 
selected endoscopists expected to play a future role in training junior endoscopists. 
The main focus was to acquire conscious competence to facilitate effective learning 
and skills acquisition.  
 TRAINING PROGRAMME FOR JUNIOR ENDOSCOPISTS 
A module-based colonoscopy training programme was developed for junior doctors. 
The programme consisted of a theory and simulator course followed by 20 days of 
supervised colonoscopies with a reduced list of six colonoscopies per day. The 
training days are to be completed within 3 months. Feasibility testing was conducted 
by five junior endoscopists in 2015 (1st to 3rd year surgical residents). Important 
lessons were learned in relation to organizing and scheduling the module-based 
training programme. Cancelled training days and surgical pagers provided anything 
but an effective and calm training environment. The solution was to move all training 
days to the outpatient endoscopy unit at Hobro hospital. The physical distance proved 
an effective barrier against last-minute cancellation and removed most disturbances 
during training days. Since the autumn of 2016, all first-year surgical residents have 
been enrolled in the modular training programme. Competence improvements are 
tracked continuously using the Assessment of Competence in Endoscopy (ACE) by 
the ASGE. Four endoscopy simulator tests using the Simbionix GI mentor and the 
Immersion Medical AccuTouch are performed before, midway and at the end of the 
module-based training programme.66,103 At present, 14 junior doctors have completed 
the programme. Evaluation and data analysis will take place when 15 doctors have 
completed the programme. 
 THE QUALITY MONITORING SYSTEM 
Development of the quality monitoring system began in March 2018 in cooperation 
with the regional business intelligence unit (BI unit). The quality monitoring system 
was developed as a supplementary file (SFI). An SFI is an electronic sheet completed 
during every colonoscopy and saved as part of the EHR. The file collects information 
on colonoscopy indication, endoscopist, CIR, polyps (numbers found , removed and 
retrieved), WT, comfort score and patient characteristics. A full list of variables and 
categories obtained from the SFI is available in Supplementary table A. An initial 
version was uploaded to a testing environment and tested on a small scale on live 
endoscopies with additional adjustments of layout and mandatory input fields. The 
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final version was released in October 2018 and implemented as a stand-alone SFI 
accessible under “new procedures” and through the “standard of care” regime, a 
regime familiar to the assistant nurses. The assistant nurse was assigned responsibility 
for completing the SFI. Feasibility testing began at Hobro hospital in November 2018. 
Implementation was conducted at a morning teaching session explaining the need and 
rationale of performance monitoring using current guidelines and data obtained from 
the paper-based survey followed by the presence of the PhD author for two days in 
the endoscopy rooms for guidance and assistance related to the SFI. Implementation 
followed at Aalborg hospital in January 2019, Thisted endoscopy unit in February 
2019, Frederikshavn endoscopy unit in May 2019 and Hjørring hospital in June 2019. 
Raw outputs are generated from the SFI by the BI analysis unit biannually and on 
special requests. Individual performance reports are sent by e-mail to each 
endoscopist and the head of the department. Each performance report contains 
individual key performance indicators compared to department average and/or 
recognized performance goals. Anonymized outputs are also presented at endoscopy 
unit meetings.  
3.3. STUDY III: COLONOSCOPY ADVERSE EVENTS  
Data for Study III were obtained through EHR review. The BI unit provided a list of 
patients in the North Denmark Region who had an outpatient colonoscopy performed 
from 1 January 2015 to 31 December 2018 and who matched one of the following 
criteria: 
• Readmitted within eight days from outpatient colonoscopy 
• Died within 30 days from outpatient colonoscopy 
• Was assigned a colonoscopy complication code within 8 days of colonoscopy. 
 
A list of outpatient endoscopy unit codes is available in Supplementary table B. 
Colonoscopies were identified using the NOMESCO Classification of Surgical 
Procedure Codes KUJF32 and KUJF35, colonoscopy with and without biopsy.95  
Colonoscopy complication codes were identified from Danish ICD-10 codes and 
defined as: DT812G1: Perforation or lesion during colonoscopy; DT810J1: Bleeding 
following colonoscopy; DT810J: Bleeding following endoscopy; DT888U1: Medical 
complication to colonoscopy; DT888U: Other complication to colonoscopy; and 
DT888L: Post polypectomy syndrome.  
 
Data capture from the EHR was conducted using the RedCap data capture tool.104 An 
initial data capture tool was designed and tested on 25 patients and small adjustments 
were continuously made to adjust logic branches and cover all AEs in concordance 
with the ASGE lexicon.72 The final RedCap data capture tool covered up to 199 
variables related to each colonoscopy. At the production stage, the first and second 
author in Study III entered 25 cases separately and agreement was sought. Another 25 
cases were entered separately with complete agreement on categorizing, attributing 
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and severity grading of AEs in 24 out of 25 cases (96%). Upon completion of all the 
1,141 potential AEs, data were exported for further analysis in Stata.100 
3.4. STUDY IV: OVERALL AND STANDARDIZED PERFORMANCE 
INDICATORS 
Data used in Study IV were obtained from the quality monitoring system described in 
section 3.2.4. An output based on an irregular 8-month period served as basis for the 
data analysis. All patient-level data (except age, sex and indication) and findings 
(except binary data on CIR and polyps) were censored to protect patient 
confidentiality and to allow for publication in an open file repository.105 Minimum 
acceptable standards were set as CIR of 90% similar to UK guidelines and PDR was 
set to 35% according to a previous study by Patel et al.50,106 Overall CIR and overall 
PDR were compared to standardized CIR and standardized PDR. Standardization was 
made by adjusting for endoscopist, colonoscopy indication, patient sex and patient 
age. Comparison of overall and standardized performance markers were conducted by 
comparing absolute changes, rank changes and correlations using Kendall’s τ.  
3.5. STATISTICAL ANALYSIS 
Study I: Statistical analysis was conducted using SAS 9.4 (SAS Institute, Cary, North 
Carolina, US). Confidence intervals (CIs) for rates were calculated assuming a 
Poisson distribution. Relative risks (RRs) when comparing countries were calculated 
according to Altman.107 A multivariable Poisson regression model was constructed 
using the PROC GENMOD procedure. An interaction between hereditary CRC and 
patient age was found. For this reason, hereditary CRC was stratified by age (below 
and above 60 years of age). 
Study II: Statistical analysis was conducted using Stata MP 15.1.100 The chi-square 
test was used for univariable comparison. Multivariable analysis controlling for age, 
sex and colonoscopy indication was conducted using logistic regression. Colonoscopy 
performance reports were generated from raw data outputs delivered by the BI unit. 
A series of Stata loops generated a performance spreadsheet containing key 
performance indicators with 95% CI on all endoscopists. The spreadsheet was 
subsequently imported to a Word template using the Microsoft Word “mail merge” 
function to generate individual performance reports.108  
Study III: Statistical analysis was conducted using Stata MP 15.1.100 The incidence of 
AEs was calculated using exact 95% binomial CIs (Clopper-Pearson). Two-sample 
test of proportions was used to compare groups (prtest). CIs on continuous variables 
were calculated assuming normal distribution. 
Study IV: Data analysis were conducted in R using the following packages: 
“Data.table”, “riskRegression”, “DescTools”, “xlsx”, “Publish” and “Hmisc”.92,109–
114 CI on continuous variables were calculated assuming normal distribution and CIs 
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on binary variables were calculated using the Wilson interval.115 Standardized CIR 
and standardized PDR were based on a logistic regression model adjusting for 
endoscopist, colonoscopy indication (screening/diagnostic), patient gender 
(male/female) and patient age (continuous). Standardized CIR and standardized 
PDR were calculated assuming every endoscopist performed a single colonoscopy 
on all patients in the database using the results from the logistic regression model. 
CIs on endoscopists performance in the standardized models were calculated using 
bootstraps with 1000 repetitions and Wald type CIs. Scatter plots of overall CIR vs 
standardized CIR and overall PDR vs standardized PDR were constructed to 
evaluate outliers and variability. Correlation was estimated using Kendall’s τ.  
3.6. ETHICAL CONSIDERATIONS 
Study I: Retrospective register-based studies are not subject to ethical committee 
evaluation in Denmark. The study was registered with the Danish Data Protection 
Agency through the Capital Region (P-2019-348). All data had encrypted CPR 
number to protect individuals.  
Study II: The paper-based survey and live-teaching colonoscopy courses were 
reported as a research project within the North Denmark Region (id: 2015-70). 
Patients participating in live-streaming courses were informed about the courses in 
advance and all patients gave written and oral consent. Paper-based surveys were 
stored in locked storage containers and digitally on locked, encrypted devices. 
Endoscopist name was irrevocably anonymized. 
Study III was conducted as a quality assurance project under the Danish health care 
act § 42d. The study was approved by the heads of all participating departments 
according to the North Denmark Region guidelines by March 2019. Data were 
collected from EHR and stored confidentially within the North Denmark Region 
RedCap system.104 Data exported for statistical analysis in Stata were stored on 
locked, encrypted devices. All patient level data such as age, sex, dates and hospital 
were omitted in the published paper to protect patient integrity and privacy. Previous 
diseases are described in broad terms and only included if necessary for the context.  
Study IV was conducted on data extracted from the SFI. All data except patient age, 
patient sex, colonoscopy indications, endoscopist, cecum intubation or polyp 
detection were removed. Endoscopist name was irrevocably anonymized to allow for 
publication of primary data. 
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CHAPTER 4: RESULTS 
This section gives a brief summary of the findings from each published or proposed 
paper.74,93,94 Tables and figure already presented within the papers are omitted, while 
results not presented within the papers are presented in full.  
4.1. STUDY I: DANISH PCCRC-3YR RATES AND FACTORS 
ASSOCIATED WITH PCCRC  
 DANISH PCCRC-3YR RATES 
• The Danish PCCRC-3yr rate from 2001-2010 varied from 2.5% to 9.1% 
depending on the method used for calculation (Supplementary figure A) 
• The Danish PCCRC-3yr rate was significantly higher than the English NHS 
PCCRC-3yr rate from 2001-2010 (RR 1.12 (95%CI 1.05-1.19)) using the Cooper 
method58,63,74  
• The Danish PCCRC-3yr rate was significantly higher than the Swedish PCCRC-
3yr rate from 2001-2010 (RR 1.15 (95%CI 1.06-1.24))74,85 
• The Danish PCCRC-3yr has been falling gradually from 22.5% in 2001 to 7.9% 
in 2012 using the WEO consensus method. A large fall occurred from 2003 
(21.4%) to 2004 (9.5%).74 
 MULTIVARIABLE REGRESSION ANALYSIS 
• The multivariable regression analysis found the following factors to be 
significantly associated with an increased risk of PCCRC74 
• Year of colonoscopy  
• 2001-2006 vs 2007-2012: RR 1.55 (95%CI 1.40-1.71) 
• Charlson Comorbidity Index  
• 1 vs 0: RR 1.20 (95%CI 1.03-1.40) 
• 2 vs 0: RR 1.25 (95%CI 1.06-1.48)  
• Colon tumour site 
• Transverse vs rectum/sigmoid: RR 1.57 (95%CI 1.28-1.94) 
• Cecum/ascending/hepatic flexure vs rectum/sigmoid: RR 1.85 (95%CI 
1.64-2.08) 
• Colon not otherwise specified vs rectum/sigmoid: RR 2.08 (95%CI 
1.74-2.49) 
• Tumour size  
• T1/T2/Dukes A vs T3/T4/ Dukes: RR 0.70 (95%CI 0.61-0-81) 
• Ulcerative colitis 
• Yes vs no: RR 3.44 (95%CI 2.79-4.23) 
• Hereditary CRC (age<60 years old)  
• Yes vs no: RR 7.39 (95%CI 5.77-9.47)  
• Hereditary CRC (age>60 years old)  
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• Yes vs no: RR 3.81 (95%CI 2.74-5.31)  
• Diverticulitis  
• Yes vs no: RR 3.25 (95%CI 2.88-3.66).  
4.2. STUDY II: IMPROVING COLONOSCOPY QUALITY THROUGH 
INDIVIDUALIZED TRAINING PROGRAMMES 
 2015: BASELINE PERFORMANCE (PAPER-BASED SURVEY) 
• A total of 838 out of 894 colonoscopy quality survey were returned by 
endoscopists (93.7%). Unreturned surveys were completed from EHR94 
• The colonoscopy quality survey was validated against the EHR on 100 
colonoscopies with no errors related to CIR or PDR  
• CIR on returned surveys was 89.7%, while CIR on unreturned surveys was 48.2% 
(p < 0.001) 
• Overall CIR was 87.1% (95%CI 84.8%-89.3%) with a lower CIR among 
diagnostic colonoscopies (85.5% (95%CI 82.6%-88.1%)) than among screening 
colonoscopies (92.2% (95% CI 87.8%-95.4%))94  
• Overall PDR was 33.7% (95%CI 30.6%-36.9%); 26.5% (95%CI 23.2%-30.0%) 
for diagnostic colonoscopies and 55.9% (95%CI 49.1%-62.7%) for screening 
colonoscopies94 
• Individual CIR varied from 74.1% (95%CI 64.6-83.6) to 96.3% (95%CI 92.1-
100.0) and individual PDR from 20.3% (95%CI 13.1%-27.5%)  to 55.8% (95%CI 
40.4%-71.3%) Baseline characteristics are available in Supplementary table C 
• Logistic regression adjusting for endoscopist, patient age, patient sex and 
colonoscopy indication found significant differences in both CIR and PDR. The 
worst CIR performer had an OR of 7.26 (95%CI 2.04-25.85) for not reaching the 
cecum (compared to the best) (Supplementary table D). The OR for finding at 
least one polyps was 2.92 (95%CI 1.38-6.17) when comparing the best and worst 
endoscopist (Supplementary table E). 
 2019: NEW PERFORMANCE (ELECTRONIC SFI) 
An output from the quality monitoring system covering a 14-week period was 
obtained in the spring of 2019 (1,488 colonoscopies). 
• Overall CIR increased from 87.1% (95%CI 84.8%-89.3%) to 92.1% (95%CI 
90.6%-93.4%) and overall PDR increased from 33.7% (95%CI 30.6%-36.9%) to 
41.7% (95%CI 39.1%-44.2%) from 2015-201994  
• The increase in both CIR and PDR was significant in the univariable analysis (p 
< 0.001)94 
• Multivariable logistic regression adjusting for indication, patient sex and patient 
age found a significantly higher OR of reaching the cecum in 2019 than in 2015, 
OR 1.63 (95%CI 1.24-2.15). The OR for polyp detection in 2019 was 1.13 
(95%CI 0.94-1.36) compared to 2015.94 
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 THE QUALITY MONITORING SYSTEM (AUTUMN 2019) 
• The first regular 6-month output covering the entire North Denmark Region was 
generated in December 2019. It covered 6376 colonoscopies 
• Validation of the SFI against booking records and EHR was performed at Aalborg 
University Hospital in the spring of 2019 covering 100 colonoscopies. Three 
colonoscopies were missing in the colonoscopy reporting system (SFI not 
completed), but cecum intubation was complete in all three cases. In five 
colonoscopies, the identity of the endoscopist was not reported 
• Validation of data from Thisted, Hjørring and Frederikshavn is pending. 
 MAJOR COLONOSCOPY PERFORMANCE INDICATORS IN THE 
NORTH DENMARK REGION  
• A total of 6,376 colonoscopies were performed in the autumn of 2019 by 81 
endoscopist, median 50, interquartile range [19-119] 
• A total of 41 endoscopists performed <50 colonoscopies during the 6-month 
period. They performed a total of 822 (12.9%) colonoscopies 
• Major key performance indicators are found in Table 4 below: 
Table 4 Key colonoscopy performance indicators in the North Denmark Region 
with individual endoscopist performance range compared to UK targets 
 North Denmark Region  Performance 
range of 
endoscopists1 
 UK quality 
standards2 
 Mean 95% CI   [min-max]  Min./aspirational 
Overall CIR 92.2% (91.5%-92.9%)  [84.3%-97.0%]  ≥90% / ≥95% 
  Screening CIR 94.0% (93.0%-94.9%)  [85.2%-100%]  ≥90% / ≥95% 
  Diagnostic CIR 91.2% (90.3%-92.1%)  [83.6%-96.2%]  ≥90% / ≥95% 
Overall PDR 42.4% (41.1%-43.6%)  [9.7%-66.1%]   
  Screening PDR 58.9% (56.9%-61.0%)  [45.6%-74.6%]   
  Diagnostic PDR 33.0% (31.5%-34.4%)  [9.7%-59.7%]   
NRCL ≤ 3 88.5% (87.7%-89.3%)  [71.8%-94.4%]  ≥90% 
Polyp retrieval rate 90.8% (90.1%-91.5%)  [74.1%-99.1%]  ≥90% 




NRCL: Nurse-reported comfort levels. WT (min): Withdrawal time measured in minutes. CIR: 
Cecum intubation rate. PDR: Polyp detection rate. 1Endoscopists with >50 observations for 
calculations. 2Minimal/aspirational targets according to the UK standard. No PDR target for 
screening colonoscopies exists (Rees CJ et al 2016). 
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4.3. STUDY III: COLONOSCOPY ADVERSE EVENTS 
 OVERALL RESULTS 
• A total of 49,445 colonoscopies were performed in the North Denmark Region  
• A total of 1,141 colonoscopies were potentially associated with AEs and 
investigated in EHRs (23.07‰) 
• EHR review left 489 AEs attributed to colonoscopy. The overall AE rate was 
9.9‰ (95%CI 9.0‰-10.8‰)93 
• Fatal AE rate was: 0.2‰ (95%CI 0.1‰-0.4‰); severe AE rate: 1.3‰ (95%CI 
1.0‰-1.7‰); moderate AE rate: 2.5‰ (95%CI 2.0‰-3.0‰); and mild AE rate 
5.9‰ (95%CI 5.3‰-6.6‰)93 
• AEs were categorized as cardiovascular (0.65‰), pulmonary (0.36‰), 
thromboembolic (0.10‰), instrumental incl. perforations (0.99‰), bleeding 
(3.07‰), infection (0.87‰), drug reactions (0.04‰), pain (2.00‰), integument 
(damage to skin/bones) (0.34‰) and other (1.62‰)93  
• Nine out of ten fatal AEs were not directly related to the colonoscopy procedure 
(bleeding or perforations), but caused by cardiovascular, thromboembolic or 
other AEs. 93 
 
 COMPARISON WITH UK QUALITY ASSURANCE GUIDELINES 
Colonoscopy perforations rates compared to UK quality assurance standards are 
found in Table 5 below. 50 













perforation rate 1 in 1030  < 1 in 1000  < 1 in 3000 
Non-polypectomy colonoscopic 
perforation rate1 1 in 2524  < 1 in 2000  < 1 in 4000 
Colonoscopic perforation rate 
where polypectomy performed 1 in 470  < 1 in 500  < 1 in 1500 
Post-polypectomy bleeding rate  
(moderate severity or worse) 1 in 277  < 1 in 200  < 1 in 1000 
Colonoscopic perforation rate 
where dilatation performed 
1 in 30  < 1 in 33  <1 in 100 
1Including colonoscopies with biopsies. Minimal standard / aspirational targets according 
to UK quality assurance standards (Rees CJ et al 2016). 
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4.4. STUDY IV: OVERALL AND STANDARDIZED PERFORMANCE 
INDICATORS 
 OVERALL AND STANDARDIZED CIR 
• Patient age (OR 0.98 (95%CI 0.97-0.99)) (per year) and screening 
colonoscopies (OR 1.62 (95%CI 1.31-2.01)) were significantly associated 
with reaching the cecum 
• The maximum rank change for an endoscopist comparing overall CIR and 
standardized CIR was 8 positions, interquartile range [1-3]. The maximum 
change in CIR was 1.95 percentage points, interquartile range [0.27-0.86] 
percentage points. Correlation measured by Kendall’s τ was 0.89 (p <0.001)     
• One endoscopist, who was  significantly “inferior” using overall CIR, came 
within 95% CI range of the 90% CIR goal using standardized CIR. 
 OVERALL AND STANDARDIZED PDR 
• Patient age (OR 1.03 (95%CI 1.02-1.03)) (per year), screening colonoscopies 
(OR 2.97 (95%CI 2.66-3.32)) and male gender (OR 1.66 (95%CI 1.50-1.83)) 
were associated with polyp detection  
• The maximum rank change for an endoscopist comparing overall PDR vs 
standardized PDR was 17 positions, interquartile range [1.5-8.5]. The 
maximum change in PDR was 11.21 percentage points, interquartile range 
[2.05-6.70] percentage points. Correlation measured by Kendall’s τ was 0.69 
(p <0.001)   
• Two endoscopists, who were significantly inferior using overall PDR, came 
within 95% CI range of the 35% goal using standardized PDR. One 
endoscopist dropped to significantly inferior using standardized PDR.  
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CHAPTER 5: DISCUSSION 
5.1. MAIN FINDINGS 
We demonstrated that it is possible to compare PCCRC rates among countries. From 
a Danish perspective, it is concerning that the PCCRC-3yr rate is higher in Denmark 
than in both Sweden and the English NHS. However, the PCCRC-3yr rate seems to 
be falling over time, indicating continuing improvement in colonoscopy quality. We 
were able to identify individuals with a high risk of PCCRC, namely patients with a 
high comorbidity index, tumours in the right side of the colon, hereditary CRC, 
ulcerative colitis and diverticulitis. If utilized properly, this knowledge may help 
reduce PCCRC-3yr rates.  
Our study to improve colonoscopy quality was successful in improving the CIR, 
although the results on the PDR were mixed. We successfully established a 
colonoscopy quality monitoring system. The CIR and PRR are significantly above the 
minimum quality assurance threshold set in the UK, and WT is above the UK 
aspirational target. There are large inter-endoscopist differences in performance, and 
many endoscopists perform relatively few procedures. A module-based training 
programme for junior doctors has now been successfully implemented. 
Colonoscopy AEs remains an important issue as AEs occur in around 1:100 
colonoscopies. The rates of perforations and bleedings in the North Denmark Region 
are just below or above the minimal UK quality assurance standards depending on 
which exact measurement is used. The study revealed AEs extending beyond directly 
procedure-related complications. Nine out of ten fatal AEs were caused by non-
procedure-related AEs. 
Standardized performance markers are useful for direct comparison of endoscopists 
performance. Standardization had little effect on the CIR and a more pronounced 
effect on the PDR. Overall CIR is a reasonable performance indicator but care should 
be taken when interpreting data on potential inferior performers. Overall PDR 
becomes unreliable in situations where an endoscopist has an outlier case-mix.    
The following sections discuss the results of each study with a focus on the methods 
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5.2. STUDY I: DANISH PCCRC-3YR RATES AND FACTORS 
ASSOCIATED WITH PCCRC  
A common PCCRC methodology 
Re-calculating PCCRC-3yr rates for direct comparison when new studies emerge 
using their own unique method is impractical, but unfortunately necessary. As seen 
from Supplementary figure A, the Danish PCCRC-3yr rates vary from 2.5% to 9.1% 
depending on the method used for calculation.4,6,8,58 Selecting a methodology for 
future reference requires careful consideration of advantages and drawback related to 
each method. The le Clercq and the Bressler methods had designs that might limit 
their use as a common method. The le Clercq method simply used PCCRC divided 
by all CRCs diagnosed in the population whether or not they were diagnosed by 
colonoscopy. The result is a large denominator and a small PCCRC rate. It is simple, 
but does not account for the general use of colonoscopy within a population. If few 
colonoscopies are performed, the rate will be negligible. Bressler chose a rather 
restricted definition of PCCRC as individuals were also required to not have a 
colonoscopy less than 6 month from diagnosis. This effectively excluded any PCCRC 
that was subsequently diagnosed by colonoscopy, leading to a smaller numerator. The 
methods proposed by Cooper and Singh were almost similar, except that the Singh 
method allowed for a CRC to be counted in both the PCCRC and DC group. Morris 
et al. developed their “new colonoscopy method” (a fifth method) on the basis of this 
comparison.63 The approach was very similar to that of the Singh methods but changed 
the analysis from year of CRC to year of colonoscopy, thus making it easier to track 
performance improvement over time.63   
The WEO consensus method published in 2019 closely follows the method by Morris 
et al., but it allows multiple CRCs in each individual.64 For instance, two CRC 
occurring years apart can, in principle, cause two DC colonoscopies and two PCCRC 
colonoscopies in the same individual. Only the last colonoscopy in each DC or 
PCCRC interval is counted. If an individual has two colonoscopies, e.g. 12 months 
and 11 months before a CRC, only the colonoscopy 11 months before the CRC is 
counted in the PCCRC category. This might seem as a smart choice as the PCCRC-
3yr rate is used as an epidemiological tool with little information available for each 
procedure as the first colonoscopy might simply be repeated due to a bad bowel 
preparation. However, this application also has drawbacks. We have experienced 
cases with multiple colonoscopies in the PCCRC category (up to three) that all missed 
the same CRC. They will be counted only once by using the WEO consensus method. 
Similarly, the DC interval of 6 month can be problematic. If a symptomatic patient 
undergoes a colonoscopy initially missing the CRC, this individual is likely to 
undergo further examination shortly after. A common examination would be CT. The 
sensitivity of CT to detect CRC depends on tumour size, but is reported at 70%-
100%.116,117 If a CRC is suspected, a new colonoscopy is likely performed within 6 
months, and the initial colonoscopy will not be counted as a PCCRC colonoscopy. 
For this reason, others have used a shorter  DC interval of 3 months.118 However, the 
WEO methods are set to be universally applied to different countries and jurisdiction 
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over a long period of time, making the 6-month interval a safer choice to ensure that 
a slow diagnostic process does not lead to misclassification. The use of year of 
colonoscopy rather than year of cancer does provide better tracking of colonoscopy 
quality over time as mentioned earlier, but it also has the unwanted effect that reported 
numbers will be somewhat old. Thus, 3 years of follow-up, another 1 or 2 years to 
ensure that all databases are updated and to process various applications followed by 
1 year of data management and publication means that published rates are likely to be 
6 years old. 
Two other factors related to calculating PCCRC rates should also be noted: The 
relative sensitivity of the date of CRC diagnosis and the effect of change in the use of 
colonoscopy over time. From 2001-2010, less than one third of CRCs had a 
colonoscopy within the preceding 3 years (Denmark: 29.4%; the English NHS: 
31.7%)63,74 (Supplementary figure A). Sigmoidoscopy was likely more common in 
this period, partly explaining the low numbers, but the exact diagnosis date might also 
be important. When an individual is admitted due to various CRC-related symptoms 
and a CRC is confirmed a few days later (by colonoscopy), the exact diagnosis date 
will be of utmost importance in PCCRC-3yr rate calculation. If the diagnosis date is 
coded as the date of admission, the CRC will not become a DC but simply be omitted 
from calculations. If the CRC diagnosis date is coded as the later date corresponding 
to the date of pathology verification or the date of colonoscopy, it will be counted as 
a DC. Attention to coding algorithms is needed to ensure that rates are comparable.  
Our finding of falling PCCRC-3yr over time is comforting, but if the way colonoscopy 
is used changes over time, the PCCRC-3yr rate might fall without any real quality 
improvements. Today, preoperative histological CRC confirmation is almost always 
performed, but the situation was likely different 20 years ago. Such a phenomenon 
seems to have affected the Danish numbers, especially in the period from 2003 to 
2004 as the PCCRC-3yr rate fell from 21.4% to 9.5%.74 This fall is mainly caused by 
an almost 3-fold increase in DC, while PCCRC remains relatively constant (Paper I: 
Table 3).74 As seen from Supplementary figure B, the driving force behind the 
increase in DC colonoscopies is “colonoscopies with biopsies”, indicating a 
preoperative regime shift.74 
The use of national registries 
Calculating the PCCRC-3yr rate requires reliable registries in relation to both 
procedures and CRCs. A previous study from the US found that almost half of 
PCCRCs were due to registry errors.119 The Danish registries are generally known to 
be accurate with a high data quality, but procedures and cancers can be miscoded, 
misclassified or misdated.43,82 A previous Danish study investigated PCCRCs in 
another context and reviewed 101 PCCRC cases identified from the DNPR/DCR.118  
The timeframe for DC was just 0-3 months with an increased risk that some CRCs 
would incorrectly be assigned to the PCCRC group. Nonetheless, 89% of PCCRCs 
were correctly assigned. Several other procedure codes have been validated in the 
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DNPR. Procedures such as hip replacements, appendectomy and cholecystectomy 
have been shown to have a positive predictive value (PPV) of 99-100% against journal 
records.82,120 Validating CRC against journal records is less simple as diagnostic 
criteria for CRC might change over time. In the DNPR, a cancer diagnosis is coded 
as a simple ICD-10 diagnosis, while the DCR relies on complex information obtained 
from the DNPR, separate registrations and pathology.43 CRC has been validated in the 
DCR against patients registered in both the DNPR and the DCR at a PPV of 88.9%.121 
The cause of the lower PPV was missing registrations in the DCR, e.g. on patients > 
75 year of age and CRC with unknown location.121 These findings indicate less 
complete registration of severely ill and older patients in the DCR. Since our study 
used CRC diagnosis from the DCR, there is a risk that some older patients and patients 
with unknown tumour location have been missed in our analysis. 
A review on validation of non-cancer diseases in the DNPR from 2015 by Schmidt et 
al. gives  a good oversight of the PPV and sensitivity of using the DNPR for diagnostic 
purposes.82 In general, studies report good PPVs and sensitivities, but using the DNPR 
is not entirely unproblematic. Relevant to our study, Crohn’s disease and ulcerative 
colitis have been validated with a PPV of 97.2% and 90.3%, respectively, but the 
identified studies are almost 25 years old and did not include outpatient visits.122 More 
recently, in 2010, diverticular disease was validated, showing a PPV of 98.0%.123 
Newer incidence studies on IBD based on the DNPR have applied a criterion 
according to which a specific number of positive records was required before a 
positive diagnosis was assigned.124 Such criteria would likely select individuals with 
more severe disease. Our use of a single previous record of either Crohn’s disease or 
ulcerative colitis could underestimate the risk of PCCRC as it might include a large 
proportion of patients with mild disease. Our definition of “hereditary CRC” as a pool 
of ICD-10 diagnosis codes should be considered when interpreting the results. 
Diagnostic criteria for hereditary CRC have changed over time, and we strongly 
suspect that the ICD-10 coding was inconsistent in relation to which hereditary code 
was used. The result is likely to be a heterogeneous group of hereditary CRC patients 
with Lynch syndrome, hereditary nonpolyposis CRC, different polyposis syndromes 
and individuals with an increased familial risk. Each subgroup has a highly different 
risk of CRC.125,126 Adding supplementary data from the Danish Hereditary Non-
Polyposis Colorectal Cancer Register would be beneficial if the relationship between 
PCCRC and hereditary CRC were to be explored further.127 However, attention to 
PCCRC rate calculations is warranted in individuals where intensive surveillance is 
performed. The Danish recommendation for Lynch syndrome is biennial 
colonoscopy. Any individual with Lynch disease diagnosed with CRC while adhering 
to the control programme would be registered with both a DC and a PCCRC. If all 
individual with Lynch disease adhered to the biennial colonoscopy recommendation, 
this would inflate the PCCRC-3yr rate to 50%. A similar effect could overestimate 
the risk of PCCRC in patients with ulcerative colitis, but Danish guidelines do not 
recommend intensive surveillance, albeit additional colonoscopies for diagnostic 
purposes are likely.128 
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5.3. STUDY II: IMPROVING COLONOSCOPY QUALITY THROUGH 
INDIVIDUALIZED TRAINING PROGRAMMES 
Reporting bias 
Setting up a colonoscopy quality monitoring system requires careful consideration to 
avoid reporting bias, a problem easily perceived from the 2015 baseline survey. The 
response was good with 93.7% of the surveys being returned by endoscopists with an 
overall CIR of 89.7%, very close to the minimal acceptable standard. Unfortunately, 
further data analysis and validation revealed that the CIR for non-responders was just 
48.2%, causing the overall CIR to decline to 87.1%, which is significantly below the 
90% minimal standards.49 To our knowledge, reporting bias on CIR has not been 
directly evaluated in any large-scale setting; however. registration bias is known to 
occur in other colonoscopy quality databases such as the Norwegian Gastronet 
database.129 It is impressive by size, but relies on positive reporting. A total of 12 out 
of 20 hospitals investigated had < 90% of procedures recorded in the Gastronet 
Database compared to the Norwegian National Patient Register. A direct comparison 
between reported and non-reported procedures has not been made, but longer 
procedure times and a low AE rate have been associated with incomplete registration 
in the database.129 A similar issue could also have affected the UK quality audit from 
2013, but nurses (not endoscopists) were charged with gathering data and validation 
was performed without indication of selection bias.3 The overall risk of selection bias 
is a “feel good” database with impressive performance, but it might not mirror  the 
actual quality. A solution to counter reporting bias is to deploy a standardized 
reporting system within the EHR that automatically reports to quality databases. The 
English National Endoscopy Database is based on such a system with automatization 
of the data capture process; however, histopathology is currently not included.77 The 
Danish CRC screening programme is based on a series of codes related to each 
procedure, thus also relying on positive reporting. The actual coding is conducted by 
medical secretaries based upon information from the endoscopy reports, which 
probably limits reporting bias. Validity has been shown to be good, but with some 
incomplete coding related to specific codes.130 Interpretation of databases (especially 
the affected codes) should be undertaken with caution; however, they are more likely 
incomplete than affected by bias.  
Implementing the reporting system 
Upon introducing the system, some concerns were raised by both assistant nurses and 
endoscopists. Some endoscopists worried how data were going to be used and 
questioned whether the system was needed; assistant nurses had concerns about time 
spent filling in the SFI and they were a bit puzzled why they, not the endoscopists, 
had to complete the form. The 2015 baseline survey became a useful tool. Results 
from the survey were presented on both local and national meetings explaining 
“reporting bias”, the low overall CIR and the large individual performance differences 
(performance gaps). The identification of known “performance gaps” in combination 
with guideline recommendations on performance monitoring helped provide a 
smoother implementation process.49,131 The SFI was designed to be completed in less 
ASPECTS OF QUALITY IN COLONOSCOPY 
52 
 
than 2 minutes once users had familiarized themselves with the concept. This might 
seem negligible, but regulatory creep could become a problem. An editorial in 
Gastrointestinal Endoscopy by an endoscopist describes how he spends 20 minutes 
filling in seven forms after every colonoscopy. The endoscopy nurse fills in another 
five forms.132 It is doubtful whether such rigid documentation is beneficial for the 
quality of the colonoscopy. 
Assigning assistant nurses responsibility for completing the SFI was successful in 
reducing reporting bias. As mentioned in section 4.2.2, validation was performed at 
Aalborg University Hospital on 100 colonoscopies without indication of reporting 
bias. It did, however, reveal that some SFI were completed without endoscopist id. 
Unfortunately, a mandatory “endoscopist id” input field (with access to a database of 
endoscopists) cannot be programmed in the current EHR.  
Assigning responsibility for completing the SFI to the assistant nurse gave rise to 
some unforeseen problems at the North Denmark Regional Hospital. Endoscopy units 
under their jurisdiction provide sedation by a nurse anaesthetist unfamiliar with the 
use of EHR and with little experience related to endoscopic procedures. We suspect 
the use of nurse anaesthetists could lead to a higher proportion of incomplete or 
missing SFIs. Validation of SFI data from the North Denmark Regional Hospital is 
pending. 
The risk of gaming 
The introduced quality monitoring system relies on PDR, not ADR. The absence of 
incorporation with histopathology could result in unwanted behavioural change on the 
part of the endoscopists, commonly referred to as “gaming the system”, by removal 
of non-adenomatous lesions. Several studies have investigated the PDR/polypectomy 
rate against the ADR and found them to be a good marker of the ADR.54,106,133 
Munchie et al. evaluated the effect of the PDR/ADR ratio when introducing 
performance monitoring based on PDR alone and found no indication of gaming.54 
UK quality assurance standards accept the PDR as a surrogate marker if the 
PDR/ADR ratio has been validated.50 US studies (that found PDR to be a good marker 
of ADR) have found PDR/ADR conversion rates of 0.64-0.68.54,55,133 Conversion rates 
in a Danish context do seem to be higher, at least in the screening context. Comparing 
our 2015 PDR (from the baseline survey) with ADR reported in 2015 (from the Danish 
screening programme), we found almost identical PDR and ADR (55.9% and 54%, 
respectively). A PhD study from the Central Denmark Region validated PDR against 
ADR on a cohort of 8,256 screening colonoscopies. PDR from the SFI was 51.9%, 
while ADR was 50.9%.79 The close relationship between PDR and ADR leaves very 
little room for PDR/ADR gaming. It should be noted that the risk of gaming extends 
beyond the PDR/ADR issue. One-and-done gaming refers to endoscopists removing 
a single adenoma with little care for examining the remaining colon.  One-and-done 
gaming has been documented in a study from the US where a veteran affairs hospital 
was comparted with private practices.134 ADR was comparable, but the number of 
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total adenomas found was higher at the veteran affairs hospital. One-and-done gaming 
might be exacerbated by economic incentives where removal of one adenoma (but not 
additional ones) provides higher reimbursement. One-and-done gaming can be 
countered by measuring total adenomas or mPPP/mAPP (see section 1.7) to provide 
a better measurement of the overall ability to find polyps.135 MPPP are not completely 
resistant to gaming, but it would require a dedicated effort to remove multiple non-
adenomatous lesions to boost mPPP. “Indication” gaming has also been described.90 
The focus on PDR/ADR is often more pronounced on screening colonoscopies than 
on other indications. If a monitoring system allows for changing indication, an 
endoscopist might boost his/her numbers on a screening colonoscopy by assigning the 
screening indication whenever an adenoma is found. Currently, the only option to 
identify indication gaming is manual validation. Since the SFI is completed by the 
assistant nurse, indication gaming would require close cooperation between the 
assistant nurse and the endoscopist to occur. Indication gaming in relation to reports 
generated by the Danish CRC screening programme is not possible as screening 
patients are identified and invited from a central registry. 
The effect of quality monitoring 
An endoscopist quality monitoring system has the ability to detect underperformers, 
but it might also by itself introduce behavioural change. This effect is generally known 
as the Hawthorne effect, where participants change behaviour in response to their 
awareness of being observed.136 The effect is believed to be higher when combined 
with an effective feedback mechanism. An audit and feedback system in colonoscopy 
has shown to improve PDR/ADR by 10-20% in some studies.131 Tinmouth et al. refer 
to two types of social norms that might enhance the effect of feedback: prescriptive 
social norms and descriptive social norms.131 Prescriptive social norms refer to each 
individual aligning his/her behaviour with behaviour expected from a recognized 
authority; in our case by comparing individual performance using performance goals 
from recognized societies (e.g. the Danish Colorectal Cancer Screening programme, 
ESGE guidelines).34,52 Descriptive social norms refer to aligning behaviour with the 
rest of the group. Providing performance goals such as department average allows the 
endoscopist to see whether he/she is performing similarly to the rest of his/her peers. 
Both concepts were utilized in our feedback report (available in Paper II). Another 
important subject is timely feedback. We chose to provide feedback twice annually, 
which is less than the quarterly feedback often used in other studies.137,138 This choice 
is, however, a trade-off between giving timely feedback and achieving a sufficient 
number of procedures. Since half of our endoscopists performed < 50 colonoscopies 
per 6 months, providing feedback more frequently would result in numbers being too 
small for any meaningful feedback.139,140 A discussion of the number of procedures 
required for meaningful feedback follows in section 5.5. 
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5.4. STUDY III: COLONOSCOPY ADVERSE EVENTS 
Identifying adverse events 
Setting up a reliable reporting system for colonoscopy AEs can be complex depending 
on the setting and jurisdiction.141 The Danish CRC screening programme documented 
that AEs occur three times more often than reported from complication codes alone.88 
A validation study of the Danish Colorectal Cancer Screening database found a high 
agreement between the database and hospital records, but newly introduced codes 
(thus relatively  unfamiliar to the medical staff) had a lower validity.130 AEs occurring 
before the patient is discharged can, in principle, easily be recorded as part of the EHR 
or by a list of complications codes as described in section 3.3.142 However, even for 
an experienced staff, an AE occurring on the same day as the procedure will be rare. 
Relative unfamiliarity with the registration codes combined with a potentially 
stressful environment during the AE could leave AEs undocumented. The problem 
related to the unfamiliarity of registration codes is likely exacerbated when AEs occur 
after discharge from the endoscopy unit. Individuals are commonly readmitted at 
emergency departments with little knowledge of colonoscopy complication-related 
coding. It is questionable whether AEs identified from positive reporting alone will 
be reliable. 
The method described in section 3.3 to identify AEs is not identical to the methods 
described in Paper III, as complication codes were omitted in the submitted paper.93 
Of the 489 AEs, 19 had a documented colonoscopy complication code. A total of 16 
patients with AEs identified from complication codes were readmitted for at least one 
night. Three patients with AEs identified from complications codes were observed 
without being admitted overnight, but all three patients were moved from the 
endoscopy unit to another department for better monitoring and thus identified as 
readmitted. The use of complications codes did not identify any additional AEs.  
European and ESGE guidelines recommend using 30-day mortality review besides 
readmission rates. However, in our study, few additional AEs were identified based 
on this recommendation.49,73 Of the 489 patients in whom AEs were identified, 18 
died within 30 days of the procedure. A total of 16 individuals were readmitted within 
8 days and thus identified anyway. Eight of the 16 individuals had a non-fatal AE, but 
died of unrelated causes within 30 days of colonoscopy. The two additional patients 
with fatal AEs identified from the 30-day mortality criteria were both attributed as 
“possible”. The two fatal cases of AEs occurred more than 8 days after colonoscopy 
and were caused by changes in anticoagulants therapy and atrial fibrillation in relation 
to colonoscopy. 
Sole reliance on readmissions to identify AEs has two major drawbacks: Mild AEs 
might be missed; and in some countries like the US hospitals and endoscopy units 
commonly operate under different jurisdictions. Without a common EHR system 
reliance on readmissions are likely to make AE reporting unreliable.72 A French study 
classified their AEs in the same way as us, using the ASGE lexicon.143 AEs were 
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identified through surveys to patients and general practitioners with telephone follow-
up and review of medical records. Overall, the AE rate was higher in the French study 
than in our study, but only due to their finding of additional mild AEs (Paper III). In 
general, the inability to identify AEs from readmissions has led to various other 
methods being used, e.g. voluntary reporting, telephone interview or postal 
surveys.72,87,144 Unfortunately, the use of different methodologies makes comparison 
of AE rates difficult.    
The timeframe for investigating adverse events 
The timeframe for identifying AEs in relation to colonoscopy is debated and ranges 
from 3 to 30 days depending on study and guidelines used49,50,71,72,87 The ESGE and 
European guidelines recommend a 7-or-8-day follow-up, the ASGE a 14-day follow-
up, while a 30-day follow-up in relation to bleeding and perforations is recommended 
in the UK.49,50,52,72 Previous studies have investigated the timeframe within which 
perforations and bleedings occur after colonoscopy. Case stories of late perforations 
diagnosed weeks after colonoscopy have been described, but a review by Panteris et 
al. in 2009 (9 studies, a total of 236 perforations) found that 98.7% of perforations 
were diagnosed within 96 hours from colonoscopy.145–147 This corresponds well with 
our findings that the last of our 48 patients with perforations was admitted on day 5 
(Paper III). Bleedings after colonoscopy (usually caused by polypectomy) are known 
to occur later; thus, case stories of post-polypectomy bleedings up to day 29 have been 
report.148 However, bleedings occurring that late are rare. A Chinese study covering 
101 post-polypectomy bleeding cases with a 20-day follow-up found the last bleeding 
to occur on day 16, with 91% of bleedings occurring day 8 or earlier.149 A US study 
covering 37 bleedings with a 15-day follow-up found the last one on day 14, with 86% 
of post-polypectomy bleeding occurring day 8 or earlier.150 Another US study used a 
30-day follow-up and found the last bleed to occur on day 13.151 In our study, the 
highest frequency of bleedings was on the same day or the day after colonoscopy with 
daily readmissions due to bleeding continuing on a constant rate until day 8 (Study 
III, Figure 1). The use of an 8-day readmission rate is likely to have missed some late 
post-polypectomy bleedings and warrants study of whether an extended 14-day 
readmission period would be applicable. The use of a 30-day period as recommended 
by UK guidelines seems somewhat excessive from an effort-reward-ratio perspective 
with very few bleedings occurring in the last 2 weeks. 
The rate of adverse events in the North Denmark Region 
The minimum standard set by the ESGE guideline is a 7-day overall or 30-day 
colonoscopy-specific readmission rate of 0.5%. Our finding of an 8-day colonoscopy-
specific readmission rate of 1% (95%CI 0.9-1.1%) seems high in comparison. The 
0.5% recommendation is based on previous studies with different methodologies for 
identifying, attributing and grading AEs. Levin et al. identified 183 possible AEs from 
16,318 colonoscopies by searching for specific ICD codes 30 days after colonoscopy. 
The EHR review left 82 “serious” complication corresponding to an AE rate of 
0.5%.152 More similar to our study was Sarkar et al., who studied 6-day emergency 
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readmission rates based on readmission for any cause. Overall readmission was 0.4% 
for diagnostic and 0.6% for therapeutic lower endoscopy, but the study also included 
sigmoidoscopies.153 The previously mentioned French study used a combination of 
questionnaires and review of EHR to identify AEs.143 The overall AE rate was high 
(2.4%). The French study used the ASGE lexicon, similar to our study. Comparing 
the rate of moderate and worse AEs left us with more comparable results with 4.7‰ 
(95%CI 3.4-6.0) comparable to our rate of 4.0‰ (95%CI 3.4-4.6). A comparison of 
bleedings and perforations to UK quality assurance guidelines found the North 
Denmark Region complication rates to be just above or below the minimal acceptable 
standards (section 4.3.2).50 This still leaves room for improvement; however, the 
results are better than readmission rates compared to ESGE guidelines would suggest. 
Non-procedure-related adverse events 
The ASGE lexicon uses unlikely, possible, probable or definite to attribute each AE 
to colonoscopy. Attributing perforations is relatively easy due to a perfect timing after 
colonoscopy and because there are few other competing risks for lower-GI 
perforation. Bleedings are slightly more complex as lower-GI bleeding following 
colonoscopy might be caused by the procedure itself or be the indication for the 
colonoscopy. As seen from Paper III (Table 2), the majority of bleeding AEs are still 
attributed as “definite”. However, “cardiovascular”, “pulmonary” and “other” AEs are 
far more challenging. The ASGE lexicon does not provide detailed description of the 
exact use of the four attribution categories; however, a similar four-point scale is used 
by the WHO Uppsala Monitoring Centre to attribute drug reactions. The concept is 
based on four categories related to timing, absence of competing causes, response to 
drug removal (dechallenge) and readministration (rechallenge).154 Only timing and 
absence of competing causes are generally useful in relation to colonoscopy. As 
described in Paper III, the majority of cardiovascular and pulmonary AEs occurred in 
individuals with pre-existing conditions, adding to the complexity and, unfortunately, 
subjectivity in attributing AEs.  
In general, there are few published studies on non-procedure-related AEs. A US study 
found a higher OR of cardiac arrhythmia within 30 days in patients undergoing 
colonoscopy than in a matched cohort undergoing arthroscopy (1.21 (95%CI 1.14-
1.28)).71 A study by Warren et al. found that colonoscopy with polypectomy increased 
the RR of a cardiovascular event compared to a matched group that did not undergo 
the procedure (1.49 (95%CI 1.27-1.74)).155 The same study also found that individuals 
with pre-existing comorbid conditions (diabetes, stroke, chronic heart failure, chronic 
obstructive pulmonary disease or atrial fibrillation) had in increased risk for AEs 
compared to individuals without the comorbid conditions when undergoing 
colonoscopy. The exact cause is unknown, but it is likely related to bowel preparation, 
sedation or the procedure itself. Dehydration and electrolyte disturbances can occur 
from bowel preparation and will likely carry a higher risk among older and frail 
individuals.156,157 Dehydration and electrolyte disturbances might also lead to 
arrhythmias among predisposed individuals.158 A study found that arrhythmias and 
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ischaemic ECG changes occurred in one third of patients with stable heart disease 
when undergoing colonoscopy.159 A change in current practice might also put some 
individuals at an increased risk. A decade ago, older individuals were often admitted 
to hospital for bowel cleansing to ensure adequate hydration, but this practice has now 
been abandoned and bowel preparation is performed at home, occasionally with help 
from home care assistance. As the use of colonoscopy increases, more frail individuals 
are likely to undergo the procedure; and for some, a combination of bowel preparation, 
sedation and/or the procedure itself might by enough for an AE to occur. 
5.5. STUDY IV: OVERALL AND STANDARDIZED PERFORMANCE 
INDICATORS  
The number of procedures needed to establish inferior performance 
In order to obtain a reliable estimate of endoscopists’ CIR and PDR, a certain number 
of procedures is needed. A low number of procedures available for calculation results 
in wide 95% CIs and difficulty in identifying inferior performers. A study estimated 
that around 500 procedures are needed to establish reliable performance markers with 
narrow CIs.140 The amount of procedures needed to establish inferior performance 
might be lower as the number of procedures required depends on the deviance from 
performance targets.139 A theoretical example is illustrated below in Figure 9. The left 
side displays an endoscopist with a “true” CIR of 85% with 95% CI. The upper 95% 
CI boundary (of the 85% CIR) crosses a minimum acceptable CIR of 90% at 180 
procedures. A numerical “5%” performance difference does not necessarily 
correspond to a specific number of procedures due to the asymmetrical CIs close to 
100%. A PDR of 30% requires almost 370 procedures to become statistically inferior 
to a 35% minimum acceptable standard (Figure 9, right). 
 
Figure 9 Procedures needed to establish significantly inferior performance 
Left: A ”true” CIR of 85% (with 95% CI) against a 90% CIR minimum acceptable standard. 
Right: A ”true” PDR of 30% (with 95% CI) against a 35% PDR minimum acceptable 
standard. CIs calculated as “exact”. 
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The concept of numbers needed to establish significantly inferior performance can 
also be visualized as a sharply rising curve as the “true” CIR approaches the 90% 
minimum acceptable performance (Figure 10). Very poor performers (a “true” CIR of 
80%) requires just 40 procedures to be significantly inferior to the 90% minimal 
acceptable standard, but a “true” CIR of 88% requires almost 1000 procedures to 
establish significantly inferior performance against the minimal 90% acceptable 
standard. 
 
Figure 10 Sample size as a function of “true” CIR 
 
Interpreting Figure 9 and Figure 10 in relation to data obtained from the SFI reveals 
limitations in our monitoring system. The median number of colonoscopies performed 
per endoscopist during the autumn of 2019 was just 50 procedures (interquartile range 
[19-119]) (section 4.2.4). From the low number of procedures follows that only severe 
underperforming will be statistically significant. It also highlight the problems related 
to splitting performance measurements into subgroups as recommended by some 
guidelines as this will reduce the procedures available for calculation.9,90 
The reliability of overall CIR and overall PDR 
Factors such as colonoscopy indication, patient age and patient sex can affect the CIR 
or  PDR/ADR.10,11,89 However, the results might be driven by large sample sizes that 
allows detection of even slight differences with statistical significance but with little 
clinical relevance.  On the other hand, if the effect of a given variable is large and the 
proportion of colonoscopies with the variable varies between endoscopists, there is a 
risk that some endoscopists might be unfairly suspected of inferior performance by 
using overall CIR or overall PDR.  
The curve illustrates the number of procedures required to establish significantly (95% CI) 
inferior performance against a 90% minimum acceptable CIR. 
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Scatterplots of standardized CIR vs overall CIR and standardized PDR vs overall PDR 
are available in Paper IV (Figure 1 and Figure 2, respectively). Overall CIR and 
standardized CIR correlate linearly and with less variability than the scatterplot of 
overall PDR vs standardized PDR. The maximum change in CIR rate from 
standardizing was just 1.95 percentage points, interquartile range [0.27-0.86] 
percentage points, lower than for the PDR analysis where maximum change was 11.21 
percentage points, interquartile range [2.05-6.70] percentage point. 
From a clinical perspective, changes occurring around the minimum acceptable PDR 
of 35% are most interesting as they identify potential underperformers. Rex et al. 
studied the effect of measuring an “overall ADR” vs “screening ADR” on changes 
around the minimum acceptable standard and found overall ADR to be a good 
performance marker.90 In our study, four endoscopists were significantly inferior 
performers according to overall PDR; two of them were still inferior despite adjusting 
for case-mix. Some endoscopists had a rather high effect from standardization. 
Endoscopist 20 changed his/her overall PDR from 27.2% (95%CI 20.7%-34.7%) to 
35.5% (95%CI 27.5%-43.6%) after adjusting for case-mix. The reason for the increase 
in endoscopist 20’s performance is an unusual case-mix with very few screening 
procedures (1.3%) (Paper IV: Table 1). Since screening colonoscopies had an OR of 
2.97 (95%CI 2.66-3.32) for finding polyps (compared to diagnostic colonoscopies), it 
becomes more challenging for endoscopist 20 to reach the minimum acceptable PDR 
of 35%. The use of overall PDR can result in some endoscopists being unfairly 
suspected of inferior performance. 
Few studies have investigated overall CIR vs screening CIR, but a Norwegian study 
found similar CIR among different colonoscopy indications, concluding that overall 
CIR is a good performance marker and that there was no need to calculate separate 
performance goals.91 The conclusion was somewhat easy to reach as they found no 
difference in CIR among indications contrary to our study where colonoscopy 
indication (p<0.001) affected the CIR (Paper IV: Table 2). Adjusting for case-mix by 
standardization did, however, have little effect on the CIR. The maximum rank change 
was eight (compared to 17 in the PDR analysis) and just four endoscopists changed 
more than five ranks. Two endoscopists were significantly inferior performers 
according to overall CIR, with endoscopist 29 moving just within 95% CI of the 90% 
minimum acceptable standard using standardized CIR. The CIR did, however, only 
change slightly from 82.7% (95%CI 75.6%-88.1%) to 84.7% (95%CI 78.9%-90.5%). 
The major factor was again few screening colonoscopies (0%). The OR for reaching 
the cecum in screening colonoscopies was 1.62 (95%CI 1.31-2.01) compared to 
diagnostic colonoscopies, giving endoscopist 29 a disadvantage in obtaining a high 
CIR. The disadvantage was, however, far less pronounced than for the PDR analysis. 
The change in CIR category from “inferior” to “in range” only occurred due to small 
changes in CIs close to the 90% minimal acceptable standard. (Paper IV: Table 3).  
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Interpreting a correlation of 0.89 (standardized CIR vs overall CIR) as strong has 
previously been proposed, but care should be taken when interpreting correlation 
coefficients.160 Correlation coefficients provide a single value between [-1;1] that 
describe the correlation between two variables, but with little information about the 
underlying distribution of data.  Kendall’s τ is not sensitive to outliers and 
heteroscedasticity (slight heteroscedasticity is visible from study IV: Figure 1) but is 
calculated based on ordinal ranks by comparing concordant and discordant pairs, 
however there is no information available whether the discordant pairs occur among 
the highest or lowest ranked endoscopists. A sequential rank agreement method 
proposed by Ekstrøm et al. allows for a deeper analysis on rank agreement depending 
on the list depth.161 Incorporating the method in our analysis would be useful.       
Study IV has other limitations. Factors such as previous hysterectomies, visceral 
adiposity, ethnicity and bowel preparation were not included in the analysis although 
previous studies found that they could affect either CIR or PDR.10,162–164 If such 
variables are distributed unevenly among endoscopists, our case-mix adjustments 
might be insufficient. The use of PDR instead of ADR does provide an opportunity to 
“game the system” by removing non-dysplastic polyps. The evidence for PDR/ADR 
gaming is negligible, but randomly assigning positive polyp findings would lead to 
non-differential misclassification and bias towards the null hypothesis in relation to 
patient age, patient gender and colonoscopy indication.54,165 There might be a higher 
focus on quality indictors in relation to screening colonoscopies, which could lead to 
isolated gaming and differential misclassification. 
As the study was conducted in a real world setting among multiple endoscopy units, 
we believe that it is generalizable (externally valid). However, endoscopy units are 
organized differently in other countries and jurisdictions. The effect of including 
colonoscopies conducted within the gastroenterology jurisdictions is unclear. Adding 
another category to the “indication” variable is likely a viable solution. The developed 
R programme can easily be extended to include additional variables and categories to 
ensure that overall CIR is reliable in other settings. The provided R programme is 
available in an open file repository and free to use and modify.105 It allows for 
calculation of overall and standardized performance indicators with customizable 
performance goals. Outputs are generated in R markdown, examples are available in 
the file repository.105,166  
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By investigaing four aspects of colonoscopy quality, we arrive at the following 
conclusions. 
PCCRC-3yr rates are higher in Denmark than in the English NHS and Sweden. This 
is concerning since 75-86% of PCCRCs are considered avoidable.8,167,168 By 2012, the 
Danish PCCRC-3yr rate was at 7.9%, yet falling over time, indicating better 
colonoscopy quality. We found that PCCRC was associated with right-sided tumour, 
small tumour size, diverticulosis, hereditary CRC, ulcerative colitis and high 
comorbidity. 
Training programmes for junior and senior endoscopists combined with a 
colonoscopy quality monitoring system were effective in improving CIR from 87.1% 
to 92.1% from 2015 to 2019. PDR also increased from 33.7% to 41.7%, but this 
increase was insignificant in the multivariable analysis. An endoscopist monitoring 
system based on an SFI within the EHR now provides biannual individual endoscopist 
feedback in the North Denmark Region. 
The overall AE rate of colonoscopies in the North Denmark Region is 1:100 
colonoscopies with a fatal AE rate of 1:5000 colonoscopies. Bleedings and 
perforations were at a rate comparable to the minimal acceptable standards from the 
UK. Non-procedure-related AEs such as “cardiovascular” and “other” AEs also 
occurred, indicating that a combination of bowel preparation, sedation or the 
procedure itself might cause AEs, especially in susceptible individuals. 
Standardizing performance markers are useful to investigate the effect of different 
endoscopist case-mix. Standardizing had a small effect on the CIR and a more 
pronounced effect on the PDR. Overall CIR are a reasonable performance marker, but 
care should be taken when interpreting significant inferior performers. 
Standardization improved the PDR for some  poor performers around 8 percentage 
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CHAPTER 7: PERSPECTIVES 
We expect the 2018 WEO consensus method to be the future benchmark for 
calculating PCCRC-3yr rates.64 The paper describing the WEO consensus method has 
currently been cited > 50 times, and two nationwide studies from England and 
Belgium have been published using it, indicating its general acceptance.69,169 Another 
key advantage of a common methodology is the relative ease of updating numbers by 
simply rerunning existing programming upon receiving updated databases. The WEO 
statement on PCCRC-rating methods also includes recommendations for investigating 
PCCRC events in EHR using a specific framework (root cause analysis).64 The first 
study using this framework to identify causes of PCCRC has recently been 
published.168 A project approved by the Danish Patient Safety Authority has been 
initiated to investigate all PCCRC events in the North Denmark Region from 2010 to 
2018 (ID: 31-1521-31). Results should be available in around 6 months and will 
hopefully provide additional insight informing our understanding of and aiding in the 
prevention of PCCRC. The WEO consensus method recommends continuous tracking 
and auditing of PCCRCs.64 Such a system is currently not in place in the North 
Denmark Region; however, it can be implemented at a relatively low cost. The 
ongoing study covers 424 potential PCCRCs over a 9-year period, which indicates 
that around 50 cases should be investigated annually. Developing and testing the 
RedCap data capture system is time consuming; still, once completed, it is estimated 
that 20-25 cases can be evaluated on a daily basis.104 The last junior doctors scheduled 
for inclusion in the training programme for junior doctors are currently being enrolled. 
We expect colonoscopy training programmes to continue beyond the present 
programme, but there are regional upcoming challenges that must be addressed in this 
respect. Lack of certified trainers remains a challenge as few surgeons seem willing 
to dedicate themselves to lower-GI endoscopy. Nurses trained in lower-GI endoscopy 
are currently performing a large proportion of the colonoscopies. It will likely become 
necessary to include them in the training of junior doctors to secure a sufficient supply 
of trainers and training colonoscopies in the future. Initiatives attempting to introduce 
nationwide training programmes are appearing. A national multiregional working 
group has created a report on future colonoscopy training that has been approved by 
the Board of the Danish Surgical Society and the Board of the Danish Society for 
Gastroenterology. This working group will play a part in future negotiations with the 
Danish Regions and the Danish health authorities and hopefully lead to improvements 
in future training and generate renewed interest in lower-GI endoscopy. We also hope 
to see future certification of endoscopists to ensure competence. The certification 
process itself warrants further consideration. A system similar to the UK-developed 
Joint Advisory Group accreditation for endoscopy units and certification for 
individual endoscopists is effective, but the complete setup is relatively complex.170,171 
The development of automated colonoscopy scores is progressing; and if a 
relationship between recognized performance indicators and automated colonoscopy 
scores can be established, the accreditation process might be simplified.172–175  
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Continuous tracking of AEs revealed procedure-related colonoscopy complications in 
the North Denmark Region to be around the minimum standard set by UK quality 
assurance guidelines.50 We hope that additional training and upcoming courses 
addressing polypectomy techniques can move rates towards the UK aspirational 
target. Inclusion of histopathology would be highly beneficial to evaluate the risk of 
perforation and bleeding for the individual endoscopist. Study III indicates that 
colonoscopy can cause both serious and fatal AEs beyond bleeding and perforations. 
Unfortunately, we were unable to calculate RRs as we had no group for comparison. 
Uploading a dataset with our confirmed AEs to Statistics Denmark (if approved by 
the Danish Patient Safety Authority) would provide the opportunity to establish 
matched comparator groups. Current guidelines recommend continuous tracking of 
colonoscopy AEs. Our 1,141 potential AEs took place over a 4-year period, indicating 
that around 300 cases need to be evaluated annually. Currently, a physician can 
evaluate 40-50 cases daily using the existing RedCap data capture system. The 
decision to implement continuous monitoring of AEs is pending. 
A new EHR is set to be implemented in the North Denmark Region by 2022. The 
EHR system is currently in place in the Central and Southern Denmark Region. We 
plan to develop a new, simplified SFI using experiences from the existing SFI and 
hopefully make it possible for the endoscopists to log in using the BI portal and track 
their key performance indicators.. Inclusion of histopathology by changing 
measurement from PDR to ADR is recommended by most guidelines. It remains 
unclear if histopathology can be automatically incorporated in feedback reports in the 
upcoming EHR system. If not, matching outputs from the SFI and histopathology 
system by CPR number, procedure codes and date would be an alternative solution. 
Another viable solution could be to extend the monitoring conducted by the Danish 
CRC screening programme to include individual performance tracking on all 
colonoscopies. Data could be used to create a nationwide colonoscopy database 
similar to the Norwegian Gastronet or the UK National Endoscopy Database.77,176 
Regionally, the multiple colonoscopy quality initiatives seem to have improved 
colonoscopy quality, at least measured by CIR. However, work remains to be done to 
comply with the latest ESGE and WEO guidelines in relation to monitoring of 
PCCRC, AEs and the incorporation of histopathology. Other local issues should 
probably also be addressed, especially in relation to the around 40 endoscopists with 
< 50 procedures per 6 months. A standard protocol for handling underperformers is 
also warranted. For now, relatively simple measures might help reduce PCCRC rates 
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Supplementary table A Data collected from the supplementary file (SFI) 
Name of input field First level Second level 
Screening 
colonoscopy? 
 Yes   
 No 
Procedure timing1  Start time:  
  Max depth time:  
  End time:  




 Yes  Intubation of the small intestine 
  Visualization of the ileocecal 
valve   Visualization of the appendix 
orificium   Ileocolic anastomosis 
  No  Bowel preparation 
   Pain 
   Stenosis 
   Impassable bend 
   Complications 
   Instrument failure 
   No indication of reaching the 
cecum 
   Other 










 No discomfort  
  Minimal discomfort  
  Mild discomfort  
  Moderate discomfort  
  Severe discomfort  
Sedation  No sedation  
  Sedated  
  General anaesthesia  




   
   
   
Continued from the preceding page 
Colonoscopy 
pathology 
 Normal colonoscopy  
  Biopsies from suspected tumour 
  Biopsies from suspected inflammatory bowel disease 
  Diverticula  
  Polyps [number] of identified polyps 
  [number] of removed polyp 
  [number] polyps sent for 
examination by the pathologist 
Notes [free text field]  
1Current time/date are inserted when clicking the box or by manual entry.  
: ”click box”, [number]: Value from 0-99; [free text field]: Up to 200 characters.  
Note: Patient age and patient sex are collected automatically from EMR. Second-level 
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Supplementary table B Endoscopy units defined as outpatient units 
Unit code Name 
7603116 Thy kirurgisk dagafdeling 
760311Ex Thy tarmkræftscreening 
8001126 Hob Kirurgisk Sammedagskirurgi 
8001129x Alb Mave-Tarmkirurgisk Amb. 
8001289 Alb Med Gastroenterologisk Amb 
800112Ex Tarmkræftscreening 
8001609 Far Medicinsk Ambulatorium 
8003079x Hjr Kirurgisk Amb. 
800307Dx Frh Kirurgisk Dagafdeling 
800307Ex Frh Tarmkræftscreening 
8003209 Hjr Medicinsk Ambulatorium 
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Supplementary table D Logistic regression for not reaching the cecum in the 2015 
quality survey 
  OR  95% CI  p-value 
Endoscopist  
    
  
 A 3.02  0.83 - 11.00  0.09 
 B 4.69 
 1.29 - 16.98  < 0.05 
 C 7.26 
 2.04 - 25.85  < 0.01 
 D 1.59 
 0.37 - 6.73  0.53 
  E  1.00        
 F 3.24 
 0.80 - 13.10  0.10 
 G 1.82 
 0.38 - 8.64  0.45 
  H 5.41   1.33 - 21.92  < 0.05 
  I 5.08   1.17 - 21.93  < 0.05 
  Low vol (n= 20-40) 3.89   1.05 - 14.43  < 0.05 
  Very low vol (n < 20) 2.44   0.66 - 9.04  0.18 
Age group        
 <50  0.25  0.10 - 0.63  < 0.05 
 50-59 0.65  0.36 - 1.16  0.18 
 60-69  1.00 
 
     
 70-79 0.93 
 0.55 - 1.56  0.15 
 >79 1.57 
 0.80 - 3.08  0.19 
Indication  
    
  
 Screening 1.00 
    
  
 Diagnostic 2.09  1.11 - 3.96  < 0.05 
Sex   
    
  
 Female  1.00 
    
  
 Male 1.00 
 
0.67 - 1.51  0.98 








Supplementary table E Logistic regression for finding at least one polyp in the 2015 
quality survey 
  OR  95% CI  p-value 
Endoscopist  
    
  
 A 1.15  0.57 - 2.32  0.69 
 B 1.53 
 0.75 - 3.10  0.24 




   
 D 1.62 
 0.78 - 3.36  0.20 
  E 2.08   1.02 - 4.25  < 0.05 
 F 2.92 
 1.38 - 6.17  < 0.01 
 G 1.74 
 0.78 - 3.91  0.18 
  H 2.27   1.01 - 5.11  < 0.05 
  I 2.46   1.06 - 5.67  < 0.05 
  Low vol (n= 20-40) 1.49   0.75 - 2.99  0.26 
  Very low vol (n < 20) 2.11   1.10 - 4.05  < 0.05 
Age group    
 
   
 <50 1.00   
 
   
 50-59 1.68  1.74 - 3.00  0.08 
 60-69 2.46 
 3.21 - 4.27  < 0.01 
 70-79 2.73 
 3.53 - 4.75  < 0.01 
 >79 2.92 
 2.97 - 5.92  < 0.01 
Indication  
    
  
 Diagnostic 1.00 
    
  
 Screening 2.97  2.01 - 4.40  < 0.01 
Sex   
    
  
 Female 1.00 
    
  
 Male 1.54 
 
1.14 - 2.07  < 0.01 


































































































































































Supplementary figure B Numbers of annually diagnosed cancers (DC) by 
colonoscopy. 
From Pedersen et al: Risk of post-colonoscopy colorectal cancer in Denmark: time 
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